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Epidemiological Study of Contributing Factors in the Development of Peptic Ulcer and 
Gastric Cancer Initiated by Helicobacter Pylori Infection in India 
Rahul Suresh Mhaskar 
ABSTRACT 
 
 Background: Helicobacter pylori (H. pylori) infection is a significant risk factor for 
peptic ulcer (PU) and gastric cancer (GC). Apart from the virulent CagA genotype of H. pylori 
environmental and dietary factors influence disease outcomes. There have been no studies 
addressing these factors in Western India. Hence, we conducted a case control study enrolling 
PU, GC patients and controls at Pune, India. 
 Methods: Risk factors for PU and H. pylori infection were assessed in participant 
interview. H. pylori status was assessed from stool by monoclonal antigen detection. To 
understand treatment effect, we followed 100 H. pylori positive patients.  
 Results: We enrolled 190 PU patients, 125 Controls and 35 GU patients. Prevalence of H. 
pylori was 61% among symptomatic patients and 45% among controls. H. pylori infection (OR: 
1.70, 95% CI: 1.03-2.89), meat (OR: 1.10, 95% CI: 1.02-1.75), fish (OR: 1.05, 95% CI: 1.02-
1.89) consumption, and family history of ulcer (OR: 1.20, 95% CI: 1.08-1.60) were risk factors 
for PU. Consumption of snacks with alcohol (OR: 0.32, 95% CI: 0.13-0.78) and history of anti-
parasite treatment (OR: 0.51, 95% CI: 0.30-0.86) were protective factors against PU. Lower 
socioeconomic status (SES) (OR: 1.10, 95% CI: 1.02-1.39), meat consumption (OR: 2.35, 95% 
CI: 1.30-4.23), smoking (OR: 2.23, 95% CI: 1.24-4.02), eating restaurant food thrice per week 
(OR: 3.77, 95% CI: 1.39-10.23) and drinking non-filtered or non-boiled water (OR: 1.05, 95% 
CI: 1.01-1.23) were risk factors for H. pylori infection. Consumption of chili peppers (OR: 0.20, 
vi 
 
95% CI: 0.10-0.37) and concurrent parasite infestation (OR: 0.44, 95% CI: 0.24-0.80) were 
protective against H. pylori infection. H. pylori infection was eradicated only in 53% (40/75) of 
treated patients. 
 Conclusion: This study indicates that H. pylori infection is associated PU. Consumption 
of meat, fish and family history of PU are risk factors for PU. Lower SES, consumption of 
restaurant food, meat, non filtered water and smoking are risk factors for H. pylori infection. 
Consumption of chili peppers and concurrent parasite infestation are protective against H. pylori 
infection while history of anti parasite treatment protects against PU. H. pylori were eradicated 
only in 53% of patients. 
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Chapter One 
Introduction 
Background 
The Medicine Nobel Prize of 2005 was awarded to an observant pathologist Robin Warren and an 
enterprising physician Barry Marshal, both from Australia, for the discovery of Helicobacter 
pylori (H. pylori) and its role in peptic ulcer disease and gastritis in 1983.[1] Since its discovery, 
the organism has generated tremendous interest among the medical researchers. H. pylori are a 
micro-aerophilic, highly motile, gram-negative spiral organisms with 4-6 flagella at one end. The 
organism has the striking biochemical characteristic of abundant urease enzyme production. H. 
pylori have a special affinity for gastric mucosa and is etiologically associated with chronic active 
gastritis, peptic ulcer (duodenal and gastric) and gastric cancer.[1] Chronic gastritis induced by H. 
pylori is usually not symptomatic but is considered to be the background of several diseases, i.e., 
peptic ulcer and gastric malignancies that typically occur in adulthood.[2] H. pylori infection is 
almost always acquired in early childhood and usually persists throughout life unless a specific 
treatment is given (spontaneous eradication is rare). H. pylori infects at least 50% of the world’s 
human population [3] and poor socio-economic condition is regarded as the most important risk 
factor for acquisition of the infection.[2, 4]  
The inside of the stomach is bathed in about half a gallon of gastric juice every day. Gastric juice 
is composed of digestive enzymes and concentrated hydrochloric acid, which can readily tear 
apart the toughest food or microorganism. Bacteria, viruses, and ingested food are all consumed 
in this deadly bath of chemicals. It used to be thought that the stomach contained no bacteria and 
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was actually sterile, but H. pylori changed that. [5] 
The stomach is protected from its own gastric juice by a thick layer of mucus that covers the 
stomach lining. H. pylori take advantage of this protection by living in the mucus lining. Once H. 
pylori is safely ensconced in the mucus, it is able to fight the stomach acid that does reach it with 
an enzyme it possesses called Urease. Urease converts urea, of which there is an abundant supply 
in the stomach (from saliva and gastric juices), into bicarbonate and ammonia, which are strong 
bases. This creates a cloud of acid neutralizing chemicals around the H. pylori, protecting it from 
the acid in the stomach. The reaction of urea hydrolysis is important for diagnosis of H. pylori by 
the breath test (UBT). Another defense H. pylori has is that the body's natural defenses cannot 
reach the bacterium in the mucus lining of the stomach. The immune system will respond to an H. 
pylori infection by sending white cells, killer T cells, and other infection fighting agents. 
However, these potential H. pylori eradicators cannot reach the infection, because they cannot 
easily get through stomach lining. They do not go away either and lead to strengthened immune 
response. Polymorphs die, and spill their destructive compounds (superoxide radicals) on 
stomach lining cells. Extra nutrients are sent to reinforce the white cells, and the H. pylori can 
feed on this. This process results in gastritis and may eventually lead to peptic ulcer and / or 
stomach cancer. It may not be H. pylori itself which causes peptic ulcer, but the inflammation of 
the stomach lining; i.e. the response to H. pylori. [6] 
Transmission of Helicobacter pylori 
The reservoirs of H. pylori appear to be numerous, but the exact mode of transmission still 
remains unproven. In developing countries, poor sanitation makes the feco-oral route the most 
common route of transmission.[7] Dirty water, milk adulterated by dirty water, or consumption of 
uncooked vegetables irrigated with or washed in water contaminated by human excrement is 
believed to be responsible. In the developed world, oral-oral transmission is likely to be the 
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dominant route, especially in situations where there is overcrowding, and more so among 
children. [8] 
In addition, communal eating habits and the parental practice of masticating food for children at 
weaning could be vehicles of infection transmission.[9] Young children also experience repeated 
colonization of the oral cavity by regurgitation, emphasizing the importance of the gastro-oral 
route. [10] Saliva and dental plaque can harbor H. pylori, and saliva could act as a vehicle of 
transmission. One of the most proven modes of transmission is via gastric intubation experiments 
or gastroscopy and removal of biopsy tissue from the stomach by non-disposable forceps.[10, 11] 
The conversion of H. pylori into viable but non-culturable coccoid form during adverse 
conditions and re-growth into the spiral vegetative form when conditions are favorable is a 
particularly intriguing concept. [12] 
Changing prevalence of H. pylori infection 
The prevalence of H. pylori is different worldwide. In the United States infection is low among 
white and economically advantaged Americans. However, minority populations have a higher 
frequency of infection: United States data indicate that African American children aged 5 to 
9 years have an overall infection frequency of 30%. Around the world, infection among children 
ranges from approximately 35% in Russia to 20% in China and Poland, 12% in Korea and 
America to <10% in France, Belgium and Finland.[13] [14] [15] [16-20] Despite high rates of 
infection in certain pockets of the globe, the frequency of H. pylori infection is declining 
worldwide. For instance, in one study conducted in Matsumoto, Japan, the rate of infection 
declined by up to 20% between 1986 and 1994 among individuals aged 9 to 70 years of age. [14, 
21]  
A recent study from Russia examined the effect of recent improvement in standards of living on 
the prevalence of H. pylori in Russian children by conducting 2 cross-sectional studies among 
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children in St. Petersburg. The first study was undertaken in 1995 and the second a decade later. 
H. pylori status was evaluated using the same ELISA method for anti H. pylori IgG (HM-CAP). 
The research found that the initial overall prevalence of H. pylori infection was 44% and 
decreased to 13% ten years later. In both studies, the prevalence increased with age. In 1995 the 
prevalence was 30% among children younger than 5 years. A decade later the prevalence in the 
same age group is 2%. The authors concluded that improvements in the standard of living in 
Russia have resulted in a marked reduction in H. pylori transmission. Different rates of 
acquisition H. pylori form the basis for the differences in prevalence of infection between and 
among populations. The changes in Russia are a dramatic example of how sensitive H. pylori 
acquisition is to improvement in standards of living.[14]  
This finding regarding socioeconomic status (SES) during childhood holds true for all subgroups 
in the United States. For instance, in a pediatric study conducted in Arkansas, children coming 
from a family with an income of <$5,000 had up to a 60% rate of infection between the ages of 
11 and 20 years, whereas those with a family income of >$25,000 had only a 15% rate of 
infection.[4] This phenomenon has also been observed in other countries. In recently developed 
countries, such as Korea although approximately 80% of individuals >20 years of age are 
infected; the prevalence of infection in young children is inversely related to the socioeconomic 
class of their family. Those aged 10 to 19 years who are in a high socioeconomic class had a 20% 
frequency of H. pylori infection, while those of the same age who are in a low socioeconomic 
class have a 60% frequency. [15]  
A study from Kazakhistan was conducted among unrelated asymptomatic individuals between the 
ages 10 and 60 years and examined various aspects of the local household environment and 
access to water. [22] The study reported that transmission of H. pylori is largely opportunistic and 
can be water borne. If the rate of H. pylori transmission is to be reduced it will require an 
improvement in overall sanitation including waste disposal, clean water, and safe food as well as 
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in household hygienic practices. A cross sectional study conducted in children residing in 
industrial and rural areas in Italy reported that the sero-prevalence of H. pylori infection was 
significantly higher in children residing in rural areas compared to those in industrial areas. [23] 
The study also found that in rural areas, children having dogs were at greatest risk for H. pylori 
acquisition but this effect was not observed among children from the industrial areas. 
Prevalence of gastric cancer in Asian countries 
There is a marked international variation in gastric cancer incidence with highest rates reported 
from Japan. It is interesting to note that despite Japan being a developed country with a lower 
frequency of H. pylori infection; it has highest frequency of gastric cancer. Similarly, frequency 
of gastric cancer is quite high in China despite a lower frequency of H. pylori infection. In 
contrast, people living in less developed countries of Asia with high frequency of H. pylori 
infection [24-31] that is acquired at an earlier age have the lowest risk of developing gastric 
cancer.[32] It has also been observed that frequency of gastric cancer differs in different parts 
within many countries; for example, in Japan [33], variation in gastric cancer risk has been well 
documented in different regions and has been presumed to be related to variation in nutrient 
consumption. In China [34], gastric cancer mortality in Changle county is about 10-fold higher 
than that in Hong Kong and has been attributed to variation in frequency of H. pylori infection in 
the two regions. In India the prevalence of H. pylori has been reported in the range of 60 % to 
80%. [27, 35-38] In India, southern [39] and eastern parts (personal observation) of the country 
experience somewhat higher frequency of gastric cancer than the western and northern parts of 
the country. This may be attributed to the underlying variation in the diet, host genetics and 
genotype of H. pylori between these diverse populations. Interestingly, similar epidemiological 
observations were made long ago in India in respect of another H. pylori related gastro-duodenal 
ailment, i.e., peptic ulcer disease. [40]  
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Peptic ulcer and gastric cancer in India 
Studies from India have shown an association between H. pylori infection and peptic ulcer.[31, 
41, 42] However, studies from India failed to show an association between H. pylori infection and 
gastric cancer.[43-45] In a study on 50 patients with gastric cancer and 50 controls with non-ulcer 
dyspepsia, H. pylori infection was detected less frequently in gastric cancer (38%, 19/50) than 
those with non-ulcer dyspepsia (68%, 34/50).[43] Another study demonstrated that 64.7% (33/51) 
patients with gastric carcinoma and 74.4% (32/43) with non-ulcer dyspepsia had infection with H. 
pylori.[44] These studies can be criticized due to small sample size with a consequent type II 
statistical error. However, these studies had inadequate reporting of follow up time. Similarly, in 
most of these studies, endoscopy-based tests were used to diagnose H. pylori infection. Since H. 
pylori is less likely to survive in a stomach lining with metaplasia. Endoscopy-based tests can be 
false negative in patients with gastric cancer due to gastric atrophy and intestinal metaplasia .[46] 
However, studies from China and Japan showed association between H. pylori infection and 
gastric cancer. [47, 48] In essence, studies from India support the role of H. pylori as the most 
important risk factor for peptic ulcers while studies elucidating association between H. pylori and 
stomach cancer suffer from poor methodological quality. 
There are some countries like India with highest frequency of H. pylori infection have the lowest 
risk of gastric cancer in contrast to the countries like Japan and China where gastric cancer risk is 
highest in the world despite a lower occurrence of H. pylori infection. This casts major objection 
to some of the simplified model of gastric carcinogenesis resulting from H. pylori infection that 
stated that if the infection is acquired at an early age particularly in presence of malnutrition, it 
may reduce gastric acid secretion, pangastritis and gastric cancer may be the likely outcome. In 
contrast, infection acquired later in life and in person with good nutritional status and normal 
gastric acid secretion would result in hyperchlorhydria and duodenal ulcer disease.[49] It is well 
documented in the literature that patients with duodenal ulcer infrequently or never develop 
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gastric cancer.[50] If this simplified model of gastric carcinogenesis would have been true, India, 
Bangladesh, Pakistan would have higher frequency of gastric cancer than Japan and China.[48] 
However, this is certainly not the case; there are certain factors apart from H. pylori infection 
such as dietary and environmental factors which modulate the prevalence of these diseases. In 
summary there are various factors along with H. pylori infection which determine the disease 
outcome. These factors are broadly classified into agent factor, host factors and environmental 
factors.  
Risk factors for H. pylori infection 
Agent factors: Cag pathogenicity island and CagA 
The Cag pathogenicity island (PAI) qualifies as an important virulence factor. Its presence is 
associated with an increased risk of peptic ulcer and gastric cancer. Biologically, the Cag PAI is 
associated with enhanced mucosal inflammation both in vivo and in vitro. The Cag PAI encodes 
a type IV secretory apparatus (a molecular syringe) that injects the CagA protein and other 
bacterial products into eukaryotic cells. [51] Most H. pylori in the world contain the Cag PAI, 
and the risk of a clinical outcome is significantly increased in association with its presence. 
However at times peptic ulcer and gastric cancer can occur in individuals infected with Cag PAI 
negative H. pylori. Even within regions where essentially all H. pylori contain the Cag PAI, there 
are marked regional differences in cancer risk, which confirms that disease outcome involves an 
interaction among host, environment, and bacterial factors. [51]  
So it appears that all strains of H. pylori are not pathogenic. Is it possible that people living in 
countries with lower frequency of gastric cancer are infected with non-pathogenic strains of H. 
pylori than people living in China or Japan? Peptic ulcer disease, which is associated with 
infection by pathogenic strains of H. pylori, has been reported a common problem in India and 
Bangladesh.[48]  
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Genotypic analysis of H. pylori strains from India showed pathogenic strains to be present in 
more than 80% of adults and children with gastro-duodenal diseases as well as in control 
population.[52, 53] Studies that used CagA antibody in patients with non-ulcer dyspepsia have 
shown that CagA antibody is detected in sera of most patients.[54] A recently completed large 
study on 279 patients with gastric neoplasms (263 gastric cancer and 16 primary gastric 
lymphoma) and controls (101 non-ulcer dyspepsia and 355 healthy subjects) showed that 
frequency of CagA IgG antibody was similar among the patients with gastric carcinoma and the 
controls, suggesting that difference in virulence factor of H. pylori, at least CagA alone, is 
unlikely to explain the variation in outcome of H. pylori infection.[55]  
So, some environmental factors and host genetic factors along with bacterial virulence factors 
such as CagA are interplaying leading to diseases. In a study from US, Korea and Colombia [56] 
in which the first-degree relatives of patients with gastric cancer were evaluated to know whether 
similar strains of H. pylori or similar environmental factors are responsible for pattern of gastritis. 
However, this study failed to show any relationship between specific virulence factors or H. 
pylori strains and specific histologic pattern or outcome even among those sharing the same 
environment in childhood. [56] However, several studies from Japan and China [57, 58] showed 
that virulence factors of H. pylori are strongly associated with gastric carcinoma. Based on the 
available evidence, one cannot conclude that in Asian countries, despite high frequency of H. 
pylori infection, low frequency of gastric cancer is related to infection with only non-pathogenic 
strains. We are not aware of any studies that document the prevalence of the most virulent East 
Asian compared to less virulent Western CagA genotype in population from India. Indeed there 
are other factors such as host genetic factors and environmental factors at play which may explain 
this dilemma. [59]  
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Host genetic factors 
Host’s genetic make-up determines in a major way response to any infection, including that to H. 
pylori. This is evidenced by the fact that relatives of patients with gastric cancer infected with H. 
pylori developed precancerous abnormalities like gastric atrophy and hypochlorhydria more often 
than those with non-ulcer dyspepsia. [60] Patients with duodenal ulcer, which is also caused by 
H. pylori, do not develop gastric cancer in contrast to other conditions associated with H. pylori 
infection, such as gastric ulcer, non-ulcer dyspepsia and hyperplastic gastric polyp. [61] These 
also depict variations in host’s response despite infection with the same organism. Japanese 
immigrants to the United States have higher gastric cancer risk than native born Americans, 
though lesser than Japanese living in Japan [48]; this suggests the importance of the genetic 
factors with additive effects of environmental factors. Difference in carcinogenic risk in people 
living in different geographical areas might be related to variation in genetic make-up among 
different races. Specific allelic variation of different genes (polymorphism) present in a 
proportion of general population may determine variation in carcinogenic potential in different 
populations in response to environmental carcinogenic exposure, including that to H. pylori 
infection.[62] Genetic susceptibility of a person may be important in a number of carcinogenic 
processes that include:  1) mucosal protection against H. pylori infection and injury by other 
carcinogens; 2) mucosal inflammatory response to infection with H. pylori; 3) degree of apoptotic 
cell death;  4) carcinogen activation and detoxification by various enzyme systems of the hosts;  
5) variability in the repair of mutated DNA; and  6) ability of the cell to proliferate in a controlled 
manner to repair the damage. 
Several studies have been carried out on single nucleotide polymorphism in relation to gastric 
carcinogenesis. [62] However, many of these studies did not take into account the role of H. 
pylori infection and dietary factors in addition to the genetic factors. Therefore, there is need of 
more data on genetic polymorphism in relation to H. pylori infection and dietary factors.  
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It is impossible entirely to separate environmental factors from genetic influences. An early twin 
study on Swedish population suggested that there was a genetic component for acquiring H. 
pylori infection and a follow-up study on the same twins’ population has questioned if there are 
genetic influences for peptic ulcer disease in common with genetic influences for H. pylori 
infection. [63] Comparisons of mono-zygotic and di-zygotic cross-twin and cross-trait 
correlations in that study demonstrated that despite the similarity in heritability for the two traits 
(peptic ulcer disease and H. pylori infection), the genetic influences for liability to peptic ulcer 
disease are independent of such genetic effects for acquiring H. pylori infection. It is feasible that 
the relationship between H. pylori and peptic ulcer disease could be mediated by familial 
environmental factors, (i.e. environmental experiences or situations that are shared by family 
members). Examples of some familial environmental factors that may mediate the association 
between H. pylori and peptic ulcer disease are diet, smoking, or drug consumption (e.g., alcohol, 
caffeine, non steroidal anti inflammatory drug consumption). [14] 
Dietary and environmental factors 
Diet may play a major role in gastric carcinogenesis. In India, southern [39] and eastern parts 
(personal observation) of the country experience somewhat higher frequency of gastric cancer 
than the northern parts of the country. Rice is the staple cereal in eastern India. Non-vegetarian 
foods, particularly fish, are very common in eastern Indian diet, which is also spicy with more 
salts. Diet in southern India is somewhat similar to that in eastern India with rice, fish, excess 
spice and salt being commonly eaten. In contrast, northern Indian diet is mainly wheat-based and 
a greater proportion of people are vegetarian. Tobacco smoking, high-temperature food intake, 
spicy food and rice eating have been shown to be risk factors for gastric cancer in India.[64] In 
another study, consumption of dry fish has been shown to be a risk factor for gastric cancer in 
India.[65] Diet has been considered to be a major factor for increased frequency of gastric and 
esophageal cancer in Kashmir province of India.[41] Similar observations have also been made in 
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several countries, including Japan where northern districts have reported a higher frequency of 
gastric cancer than southern district and this has been related to increased dietary intake of salts in 
northern districts.[32] Tobacco use and alcohol consumption are the other factors that may 
influence the international variation in frequency of gastric cancer.[66] 
There are certain protective factors against H. pylori infection and diseases caused by it. 
Interestingly there are certain elements in the diet which are noted be a protective factor against 
H. pylori and in turn lowering the risk of peptic ulcers and gastric cancer. Some examples are 
ginger, chili peppers, and turmeric.[67-70] 
Another protective factor against disease caused by H. pylori infection which is recently shown 
promise in the research is concurrent helminth infection. Interestingly concurrent enteric helminth 
infection has shown to modulate inflammation and gastric immune responses and reduces 
helicobacter-induced gastric atrophy.[71]  It is well know that the progression of helicobacter-
induced gastritis and gastric atrophy mediated by type 1 T-helper cells may be modulated by 
concurrent parasitic infection. [71] Here, in mice with concurrent helminth infection, 
helicobacter-associated gastric atrophy was reduced considerably despite chronic inflammation 
and high helicobacter colonization. [71] Thus, concurrent enteric helminth infection can attenuate 
gastric atrophy, a premalignant lesion. Moreover in a study conducted among children in 
Columbia suggest that intestinal helminthiasis in children promotes Th2-polarizing responses to 
H. pylori and may decrease gastric cancer risk in these individuals later in life. [72] Concurrent 
helminthiasis may alter inflammatory responses to H. pylori and thus affect the progression of 
gastritis to gastric atrophy, dysplasia, and cancer. [72] 
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Summary of risk factors for H. pylori infection 
In summary, it is estimated that 50% of the world’s population is infected with H. pylori and 
approximately 20% will develop peptic ulcer disease.[73] Factors that may influence the 
acquisition of H. pylori infection are geographic area, age, race, ethnicity, and SES.[74] The 
prevalence of H. pylori infection in developing countries can be >80% in children under 10 years 
old and in developed countries it can be up to 50% of children living in poor socioeconomic 
conditions.[75] High prevalence of infection have been reported in India, Africa, Latin America, 
and eastern Europe.[73] A study of a population from, the US-Mexico border, found a higher H. 
pylori sero-prevalence among preschool children in a developing country than in a developed 
country location indicating that geographic variation is an important risk factor.[76] Other risk 
factors that have been associated with high prevalence include having an infected mother [77], an 
infected older sibling [78], low SES, household crowding, migration from high prevalence 
regions, urban residence [78], indicators of poor nutritional status, drinking water source [79], 
consumption of raw vegetables [80], and low maternal education. [76, 81] Birth order has also 
been identified as a risk factor for H. pylori. A study done in Japan showed that younger siblings 
had a higher risk for H. pylori infection than older siblings.[82] We have summarized the risk 
factors for H. pylori infection in Table 1. 
Table 1: Risk factors for H. pylori infection 
Risk factor Association 
with H. 
pylori 
Reference 
Gender Male (adults) Increased 
risk 
Martel et al 2006 [83] 
Age Increasing age 
(in children) 
Increased 
risk 
Cullen et al 1993 [84]; Mendall et al 1992 
[85]; McCollian et al 1997 [86] 
 Increasing age 
(in adults) 
Increased 
risk 
Parsonnet et al 1992 [87]; Cullen et al 
1993  [84]; 
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Risk factor Association 
with H. 
pylori 
Reference 
Animals pets at home increased 
risk 
Rothenbacher 1998 [88]; Moreira et al, 
2004 [81]; Herbarth et al, 2001 [89] 
  no 
association 
Webb et al, 1994 [90]; Luzza et al, 1998 
[91]; Bode et al, 1998 [92] ; Bazzoli et al, 
2001 [93]; Brown et al, 2001 [94] 
 Sheep higher risk Goodman et al, 1996 [95]; Dore et al, 
1999 [96] 
Occupation Endoscopists increased 
risk 
Liu et al, 1996 [97]; Lin et al, 1994 [98]; 
Su et al, 1996 [99]; Mitchell et al, 1999 
[5] 
  no 
association 
Braden et al, 1997 [100]; Nishikawa et al, 
1998[101] 
 Dentists no 
association 
Lin et al, 1998 [102]; Banatvala et al, 
1995 [103] 
  increased 
risk 
Matsuda et al, 2005 [104] 
 endoscopy and 
dentistry 
nurses 
no 
association 
Lin et al, 1998 [102] ; Banatvala et al, 
1995 [103] 
 direct contact 
with patients 
Increased 
risk 
Mastromarino et al, 2005 [105] 
Water source  increased 
risk 
Nurgalieva et al, 2002 [22]; Fujimura et 
al, 2004 [106]; Rolle-Kampczyk et al, 
2004 [107]; Herbarth et al, 2001 [89] 
  no 
association 
Yamashita et al, 2001 [108]; Reshetnikov 
et al, 2001 [109] 
Diet consumption of 
fruit and 
vegetables  
decreased 
risk 
Goodman et al,1996 [95]; Goodman et 
al,1997 [80]; Fontham et al, 1995 [110] 
 Garlic, ginger decreased 
risk 
Jonkers et al [67] 
 Curcumin decreased 
risk 
Foryst-Ludwig et al [68]; Mahaday et al 
[69] 
 Chili peppers decreased Jones et al [111]; Lopez Carillo et al [112] 
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Risk factor Association 
with H. 
pylori 
Reference 
risk 
 milk and fat increased 
risk 
Guo et al, 2002 [113] 
 vitamin C decreased 
risk 
Jarosz et al. 1998 [114]; Goodman et 
al,1997 [80]; Fontham et al, 1995 [110] 
  increased 
risk 
Malaty et al, 1998 [115] 
 Beta-carotines increased 
risk  
Goodman et al, 1997 [80] 
 Meat and fish increased 
risk 
Qasim, Webberly, Phukan, Olfasson [116-
119] 
 Salt increased 
risk 
Kato, Fox, Gamboa [120-123]  
Previous 
antibiotic 
treatment 
 no influence Rothenbacher et al, 1997 [124]; Tindberg 
2001b [125]; Leung et al, 2002 [126] 
  decreased 
risk 
Rothenbacher et al, 1998 [127]; Bures et 
al, 2006 [128] 
Socio-economic 
status  
lower SES  increased 
risk  
Reploge et al, 1995 [129]; EUROGAST 
study group, 1993 [130]; Malaty et al, 
1992 [131]; 1994 [132] ; 1996 [16]; 
Murray et al, 1997 [133]; Peach et al, 
1997 [134]; Hopkins et al, 1993 [135]; 
Chow et al, 1995 [136]; Buckley et al, 
1998 [137]; Rotbenbacher et al, 1998 
[138]; Webb et al, 1994 [90]; Souto et 
al,1998 [139]; Torres et al, 1998 [140]; 
Reshetnikov et al, 2003 [30]; Bani-Hani et 
al, 2006 [141]  
  no 
association  
Teh et al, 1994 [142]; Mendall et al, 1992 
[85]; Koch et al, 2005 [143]  
Hygiene 
practices  
poor hygiene 
conditions  
increased 
risk  
Peach et al, 1997 [134]; Goodman et al, 
1996 [95]  
  no 
association 
Breuer et al, 1996 [144]; Mendall et al, 
1992 [85]  
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Risk factor Association 
with H. 
pylori 
Reference 
 sharing a cup 
or toothbrush  
decreased 
risk  
Moreira et al, 2004 [81]; AI-Shamahy et 
al, 2005 [145]; Bani Hani et al, 2006 
[141]; Peach et al, 1997 [134]; Breuer et 
al, 1996 [144]; Rodrigues et al, 2004 
[146] 
 raw vegetables  increased 
risk  
Goodman et al, 1996 [95]; Hopkins et al, 
1993 [135]  
Attendance at a 
day care centre  
 increased 
risk  
Parsonnet, 1995 [147]; Dore et al, 2002 
[23]  
  no 
association  
Tindberg et al, 1999 [148]; Wizla-
Derambure et al, 2001 [149] 
Institutionalized 
persons  
 increased 
risk  
Nessa et al, 2001 [150]; Wallace et al, 
2002 [151] 
Mouth-to-
mouth contact  
 increased 
risk  
Chow et al, 1995 [136]; Moreira et al, 
2004 [81]  
 
Living density  crowded 
environment  
increased 
risk  
Peach et al, 1997 [134]; Kikuchi et al, 
2002 [152];   
Goodman et al, 1996 [95]; Breuer et al, 
1996 [144] Rothenbacher et al, 1997 [153] 
and 1998 [138]; Kyriazanos 2001 [154]; 
Grimm 2003 [155]; Rodrigues et al, 2004 
[146]; Bani Hani et al, 2006 [141]; 
  no 
association  
Tindberg, 2001[125]  
Educational 
status of parents  
higher 
educational 
status  
decreased 
risk  
Moreira et al, 2004 [81]; Bani Hani et al, 
2006 [141]; Bures et al, 2006 [128]  
Family  H. pylori 
positive family 
member  
increased 
risk  
Ma et al, 1998 [156]; Brenner et al, 1998 
[157]; Goodman et al, 2000 [158]; 
Dominici et al, 1999 [159]; Rothenbacher 
et al, 1999 [160]; 2002 [161]; Tindberg, 
2001 [125]; Rocha 2003 [162]; Kivi et al, 
2005 [163]; Aguemon et al, 2005 [164]; 
Rowland et al, 2006 [77]  
 siblings  increased 
risk  
Kikuchi et al, 2002 [152]; Breuer et al, 
1996 [144]; Glynn et al, 2002 [165]; 
Selimoglu et al, 2002 [166]; Farrell et al, 
2005 [167]; Kivi et al, 2005 [163]  
Parasites Helminthes Decreased 
risk 
Fox et al [71, 168, 169] 
CagA genotype  Increased 
risk 
Azuma, Atherton, Al Marhoon ,Alarcon, 
Akimoto [170-176] Evans, Handa, Salih 
[177-179] 
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In summary, possible explanation of the reported low prevalence of peptic ulcer and stomach 
cancer with high prevalence of H. pylori in some parts of world such as India, might be related to 
difference in diet, environment factors (including helminthes co infection) and prevalence of H. 
pylori genotype between different countries. Hence to address this discrepancy we undertook a 
cross sectional study in Ecuador and Panama followed by a case control study in India.   
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Chapter Two 
Study Methods Description 
Assessment of H. pylori prevalence and its risk factors among healthy individuals in 
Ecuador and Panama 
We conducted a cross sectional study in Ecuador and Panama to assess risk factors contributing 
to prevalence of H. pylori and its genotypes in healthy individuals. The study was conducted in 
Ecuador and Panama from May 2007 to August 2007. All participants were screened for age and 
medical history in order to select asymptomatic adult individuals. In this study, asymptomatic 
individuals were defined as those who have not had any subjective symptoms of gastric disorders 
or have not been diagnosed with any stomach diseases by a medical doctor within the last 6 
months. Those individuals who had taken antibiotics within 6 months were excluded. A total of 
90 and 75 participants living in Ecuador and Panama, respectively, were enrolled in the study. All 
of the participants gave their informed consent. The research protocols were approved by the 
ethics committees of the University of South Florida (Tampa, FL), Universidad Central del 
Ecuador (Quito, Ecuador), and Instituto Gorgas de Estudios de la Salud (Panama City, 
Panama). 
Data Collection 
 Clinical specimens: 
The study used stool samples. After signing the informed consent the participants were given an 
empty container for stool sample collection. The participants were requested to collect the stool 
sample and bring it back to the clinic the next day. The participants were notified of the parasitic 
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infections if detected. We carried out the tests in a laboratory in capital of Ecuador. The stool 
specimens were delivered to this laboratory at 4ºC and stored at -20ºC until used.  
  Participant Interview: 
After getting the informed consent from the participants, local physicians participating in this 
research interviewed the participants using a structured questionnaire. The questionnaire dealt 
with issues of food habits, alcohol and cigarette consumption etc. Each interview lasted for on 
average of 20 minutes (range: 15 minutes - 45minutes). The interviewer marked the responses in 
the survey questionnaire. The form had a unique center and subject ID marked on it. 
 Detection of Helminthes 
Stool samples were emulsified in Protofix, ALPHA TEC, Canada.  The identification of 
helminthes was made morphologically following the guidelines of the American Society of 
Parasitology. 
 Detection of Helicobacter pylori Antigen  
H. pylori antigen (catalase) in stool specimens was detected using a rapid test kit (Testmate Rapid 
Pylori Antigen, BD, Tokyo, Japan) by following the manufacturer’s instructions. Briefly, a 20-mg 
stool specimen was taken and suspended in the sample dilution buffer (a component of the kit). 
One drop of the stool suspension was used for the immunochromatography test. The reaction was 
carried out at room temperature for 10 min. 
The rapid test kit (Testmate Rapid Pylori Antigen, BD, Tokyo, Japan) uses monoclonal antibodies 
that react specifically to native catalase H. pylori antigens.[180, 181] If these antigens are present 
in the stool sample, they form immune complexes with the red latex–labeled anti–H. pylori 
mouse monoclonal antibodies and migrate by capillary action and then are captured by solid-
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phase anti–H. pylori monoclonal antibodies to form a red test line. Red latex–labeled anti–H. 
pylori monoclonal antibodies not forming immune complexes migrate further up to be captured 
by solid-phase IgG rabbit polyclonal antibodies forming a red control line. The results were read 
in the test window as follows: the result was considered positive if both control and test lines 
appeared, negative if only the control line appeared, and uncertain if only the test line appeared.   
Since the sensitivity and specificity of the antigen detection method used in this study were high, 
bacterial DNA was extracted from H. pylori antigen-positive stool specimens. The DNA 
extraction was performed using a QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA) 
according to the manufacturer’s instructions. The bacterial DNA extraction method we used has 
been previously used in H. pylori detection with good results. Approximately 1 g of each stool 
specimen was suspended in 3.0 mL ASL buffer (a component of the kit). After mixing the 
suspension, approximately 1.2 mL of supernatant was used for the extraction. The extracted DNA 
was dissolved in a volume of 200 μL AE buffer. All extracted DNA was stored at –20°C until 
used. [182] 
As a template, 50 ng/μL or a 10-fold diluted solution of the extracted DNA was used for PCR in 
consideration of the reducing inhibitors present in stool specimens. For detecting the 16S rRNA of 
H. pylori, real-time PCR was performed using TaqMan Universal PCR Master Mix (ABI, Foster 
City, CA) according to the method described by Yamazaki and colleagues using the “ABI PRISM 
7700 Sequence Detection System’’(Applied Biosystems).[183]  
The conditions for real-time PCR were as follows: 95°C for 15 min, followed by 50 cycles 
consisting of 95°C for 15 seconds and 60°C for 1 minute.  
For genotyping of CagA, nested PCR was adopted. The first-round PCR was performed with 2 
primer sets: Forward/Reverse-1 and Forward/Reverse-2.  
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The conditions for the first-round PCR were as follows: 95°C for 2 minutes, followed by 40 
cycles consisting of 94°C for 15 Seconds, 55°C for 30 Seconds, and 68°C for 1 minute.  
The second-round PCR for genotyping of CagA was performed with 1 μL of the first-round PCR 
products as a template.  
The second-round PCR conditions were as follows: 94°C for 2 minutes, followed by 50 cycles of 
98°C for 10 Seconds and 65°C for 2 Seconds.  
PCR products of the predicted size were obtained as visualized by 2% agarose gel electrophoresis 
with ethidium bromide staining. The specificity of the PCR was determined in several samples by 
sequencing of the PCR products. The discriminatory power of the genotyping method was 
validated using reference strains. The sensitivity of the method was assessed by a spike test. That 
is, serial 10-fold dilutions of H. pylori TK1023 (an East-Asian genotype CagA-positive strain) 
suspension in phosphate-buffered saline were added to an H. pylori-negative stool followed by 
DNA extraction and PCR. The sensitivity of the method used was 215 ± 14 colony forming unit/g 
stool for 16S rRNA by real-time PCR. [182] 
Data Entry 
Data entry was done in an MS Access database.  The database was secured with a password 
known to only principal investigator and the co- investigators.  
Data Analysis 
The association between various risk factors and H. pylori status was analyzed by chi-square test 
or Fisher’s exact test. The level of statistical significance was set at P<0.05. 
  
21 
 
Assessment of risk factors for peptic ulcer and gastric cancer along with H. pylori infection 
in India 
We conducted a case control study in India enrolling patients diagnosed with peptic ulcer, 
stomach cancer and controls. We assessed the prevalence of H. pylori along with its risk factors 
among healthy individuals, and patients diagnosed with peptic ulcer and stomach cancer in Pune, 
India. We also followed a cohort of 100 H. pylori positive individuals to assess the effect of 
treatment. 
Study location: We conducted our study at Pune city in the state of Maharashtra in India at 
Deenanath Mangheskar Hospital and Research Center (DMH) between Spring 2008 – Fall 2010.  
DMH caters to all strata in the Pune population and is central mutli-speciality hospital. In this 
multidisciplinary tertiary level DMH, over 60 research projects are being conducted by young, 
highly qualified, abroad-trained, experienced consultants and medical and paramedical men & 
women, social workers, clinical psychologists, counsellors and so on. The unique location and 
services offered with a strong commitment to clinical research made DMH the hospital of choice 
for our study.  
Study Methods 
Study design 
Hospital based case control study. We carried out the case control study with three groups. 1) 
Peptic ulcer group: patients diagnosed with peptic ulcer (as defined by hospital record using 
international classification of diseases (ICD) 10 codes) 2) Stomach cancer group: patients 
diagnosed with gastric cancer (as defined by hospital record using ICD 10 codes) and 3) Controls: 
patients obtaining medical care at DMH hospital but not diagnosed with either peptic ulcer or 
stomach cancer  
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We also followed a cohort of H. pylori positive patients (n =100) during their first visit to DMH. 
We enrolled consecutive patients with H. pylori positive patients during their first visit to DMH 
until we accrued 100 patients.   
We obtained the approval from the institutional review board at University of South Florida and 
from the DMH Institutional Ethics Committee (IEC). We revised the questionnaire which was 
used in Panama and Ecuador studies by Sasaki and colleagues to suit to the population in Pune, 
India.[184] The questionnaire was pilot tested at the DMH in a small focus group enrolling some 
affiliated physicians and their patients (n=15). Based on their feedback the questionnaire was 
revised at least 5 times (specifically the questions related to food, diet, smoking habits etc.). We 
translated the questionnaire into the native Marathi language and back translated it in English 
language to assure consistency in terms of content and criterion validity.  
The cases were identified via the DMH database using the ICD10 coding. Any patient more than 
18 years of age and listed in the DMH database as having diagnosis of either peptic ulcer or 
stomach cancer was eligible for enrollment. The cases which were enrolled from the satellite 
clinics were enrolled if they were diagnosed (as being either suffering from peptic ulcer or 
stomach cancer) by their respective attending physicians. We used SAS software random number 
generation code to generate a list of potential eligible patients. We recruited the cases (patients 
diagnosed with either peptic ulcer or stomach cancer) at the beginning of the study enrollment 
followed by controls. The study personnel contacted the patients in the hospital and requested 
them to participate in the study. If the potential participant agreed to participate he / she were 
requested to sign the informed consent form. Each participant was given a copy of the signed 
informed consent form. The study was explained in details to each potential participant in their 
native “Marathi” language by the study personnel. 
Data Collection 
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We trained 2 local physicians (RAs) to collect data for this project. They were involved in the 
project since the revision of the data collection questionnaire. Since they are practicing physicians 
in Pune city they had adequate experience and knowledge of local customs and traditions 
(especially related to dietary habits etc.). They sent the completed questionnaires every weekend 
to principal investigator. We discussed the collected data and resolved any discrepancies by 
consensus. Methods for data collection and analysis of stool samples were standardized with all 
researchers participating in this study.  
H. pylori antigen detection   
All the tests were performed by the trained lab technicians at the DMH pathology lab. We 
detected the H. pylori antigen from stool specimens using the ImmunoCard STAT HpSA antigen 
detection kit. The details of the ImmunoCard STAT HpSA test and the standard operating 
procedures that were followed by the DMH pathology laboratory staff are listed below. 
ImmunoCard STAT HpSA test 
ImmunoCard STAT HpSA is a rapid lateral flow immunoassay that utilizes a monoclonal anti-H. 
pylori antibody as the capture and detector antibodies.  A diluted patient stool sample is dispensed 
into the sample port of the test device and the appearance of a pink-red line in the reading 
window next to the letter T after five minutes of incubation at room temperature indicates a 
positive result. (Figure 1) 
Specimen 
 Preferred sample types 
Only solid, semi-solid or liquid samples were accepted. We rejected samples in transport 
media and swab samples or samples mixed with preservatives. 
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Interfering substances 
The following substances have shown to have no effect on results when present in stool at the 
concentrations indicated in the parenthesis.[185] 
Tums® Antacid (5 mg/mL), Tagamet® (5 mg/mL), Prilosec® (5 mg/mL), Mylanta® Antacid 
(1:20), Pepto-Bismol® (1:20), Barium sulfate (5%), Whole Blood (50%), Leukocytes (50%), 
Mucin (3.4%), Stearic acid/palmitic acid (fecal fat) (4%), Hemoglobin (tarry stool) 
(12.5%).[185] 
Specimen Collection 
The specimen were transported in an airtight container and stored at 2º-8º C until tested.  The 
specimen were tested as soon as possible, but were at times held up to 72 hours at 2º-8ºC prior to 
testing.  If testing was not performed within this time frame, specimens were frozen immediately 
upon receipt and stored frozen (≤ -20ºC) until tested.  Specimens were frozen and thawed twice if 
required (in case of transportation or other delays in analysis were expected). Stool sample was 
thoroughly (regardless of consistency) mixed before testing. 
Materials  
1. ImmunoCard STAT HpSA Test Devices, in individual foil pouches with a desiccant. 
2. Sample Diluent, in a plastic dropper vial.   
3. Positive Control, in a plastic dropper vial.   
4. 100 µL transfer pipettes. 
Preparation and Performance considerations 
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Specimens and reagents were brought to room temperature (20º-26º C) before testing. As patient 
specimens may contain infectious agents, they were handled and disposed of as potentially 
biohazardous. We instructed the lab technicians not to interchange reagents from different kit lot 
numbers. We allowed kit components and specimens to reach the room temperature (20º-26º C) 
before performing a test, as cold reagents and/or specimens may decrease assay sensitivity.  
Reagents took 20-30 minutes to warm following refrigeration. We mixed the stool samples 
thoroughly (regardless of consistency) to ensure a representative sample prior to sampling. 
Following were the instructions given to the DMH pathology laboratory personnel to ensure 
fair and unbiased testing of the stool samples. 
 Lab technicians were instructed to inspect test devices before removing the foil pouch. They 
were also told not to use test devices that had holes in the foil pouch or where the pouch has 
not been completely sealed. (False negative reactions may result due to deterioration of the 
improperly stored Test Device.) 
 Similarly, lab technicians were instructed not to use the sample diluent or positive control if 
turbid.  Turbidity may be a sign of microbial contamination. The positive control was handled 
as potentially infectious even though it contains inactivated H. pylori.  
 Lab technicians were instructed to hold reagent vials vertically when dispensing drops to 
ensure consistent drop size and delivery. 
 Lab technicians were requested to not deviate from the method described here or falsely 
positive or falsely negative results may occur. 
 Lab technicians were instructed to thoroughly read the test instructions before performing any 
testing and to not use a device if its pouch was punctured prior to use. 
 Lab technicians were made aware that at times particulate matter may initially interfere with 
sample flow.  In cases where the test device does not readily absorb the diluted specimen, 
gently touch the bottom of the sample port with an applicator stick, moving the stool solid 
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particle that might prevent the absorption. Alternatively, a new aliquot of the sample can be 
withdrawn from the diluent and retested. 
 Lab technicians were instructed to store kit refrigerated at 2º to 8º C and return the test kit to 
the refrigerator promptly after each use.  Lab technicians were instructed to not freeze the kit. 
Quality control 
The reactivity of ImmunoCard STAT test devices was verified upon receipt using the 
external positive and negative control reagents provided in the kit. We evaluated the test in 
the following manner. 
 Internal controls 
Internal controls are contained within the test device and therefore were evaluated with each 
test.  
1. A colored band appearing at the control line served as a positive control and 
indicated that the test has been performed correctly, that sample was added, that it flowed 
properly, and that the test reagents were active at the time of use.   
2. A clear background around the control or test lines served as a negative control.  
A background that obscures the reading of results invalidates the test and can be an 
indication of reagent deterioration, inappropriate sample or improper test performance. 
 External controls:  The reactivity of ImmunoCard STAT HpSA Test Devices were 
verified upon opening each new kit using the external Positive and Negative Control 
reagents provided in the kit.  Each operator was strictly advised to test a positive and 
negative control at least once with each 20-test kit.   
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Procedure 
(Each lab technician was given a print out of the following standard operating procedure for 
performing this test.) 
 A. Test 
1. Bring all test devices, reagents and samples to room temperature (20º-26º C) before testing. 
2. Use 1 ImmunoCard STAT Test Device for each patient sample. 
3. Remove the ImmunoCard STAT Test Device from its foil pouch.  The Test Device is 
marked to indicate where test and control lines will appear.  The round window marked 
with an arrow is the test window where sample is added.  
4. Label the device with the patient’s name.  Prepare the specimen according to the 
instructions in the specimen collection and preparation section above. 
5. Hold the diluted specimen vial upright and tap the bottom gently on the countertop before 
proceeding. 
6. Cover the top of the diluted sample vial with absorbent paper to avoid splatter. 
7. Break off the red tip on the outside of the red cap.  (Do not break off the white applicator 
stick on the inside of the cap.) 
8. Hold the vial upside down and dispense 4 drops of diluted sample into the round window 
(at arrow) of the Test Device.  Do not touch the tip of the vial to the Test Device. 
9. Set a timer and incubate the test at 20º-26º C for 5 minutes. 
10. At the end of 5 minutes, read the results within 1 minute.  See the Interpretation of results 
28 
 
section below for a description of positive and negative test results. 
B. Alternate Test Procedure with Simple Sample 
Simple sample is an alternate sampling unit that can be used in place of the Sample Diluent 
vial provided with ImmuonoCard STAT HpSA test kit. 
1. Bring all test devices and Simple Sample dilution vials to room temperature (20º-26º C) 
before testing. 
2. Use 1 ImmunoCard STAT Test Device for each patient sample. 
3. Remove the ImmunoCard STAT Test Device from its foil pouch.  The Test Device is 
marked to indicate where test and control lines will appear.  The round window marked with 
an arrow is the test window where sample is added.  
4. Label the device with the patient’s name.  Prepare the specimen according to the 
instructions in the Simple Sample package insert. 
5. Mix specimen by inverting the Simple Sample several times. Remove the translucent 
screw cap from the tip of the Simple Sample. 
6. Hold the Simple Sample vial upside down and dispense 4 drops of diluted sample into the 
round window (at arrow) of the Test Device.  Do not touch the tip of the vial to the Test 
Device. 
7. Set a timer and incubate the test at 20º-26º C for 5 minutes.   
8. At the end of 5 minutes, read the results within 1 minute.  See the interpretation of results 
section below for a description of positive and negative test results. 
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C. Controls 
Positive and Negative Controls are designed to show all reagents are reactive, specific, and 
capable of producing the expected results. 
a. Bring all control reagents to 20º-26ºC before testing. 
b. Use 1 ImmunoCard STAT Test Device each for a Positive and Negative Control.  
Label each device with the control to be tested. 
c. Hold reagent vials upside down to dispense reagents.   
d. Add 4 drops of the Positive Control to the test window (at arrow) of 1 device.  Do not 
allow the tip of the vial to touch the sample port. 
e. Break off the red tip on the outside of the red cap of an unused vial of Sample 
Diluent.   
f. Dispense 4 drops of the Sample Diluent to the test window (at arrow) of another Test 
Device. 
g. Set a timer and incubate the tests at 20º-26º C for 5 minutes. 
h. After 5 minutes, read the results within 1 minute of test completion. 
Interpretation of results 
Negative test result 
Only one BLUE colour band (Control Line) appears across the central window of the 
device close to the letter “C”.  (H. pylori antigens are absent or below the level of 
detection.)  No other bands should be seen.   
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Positive test result 
 In addition to the BLUE band (Control Line), a distinguishable PINK-RED band (Test 
Line) also appears across the central window of the device close to the letter “T”.  The 
intensity of the band will vary depending on the antigen concentration in the specimen.  
Any pink-red line, even very weak, must be considered as a positive result.  (A positive 
test line indicates that H. pylori antigens are in the specimen.)   The background should 
not interfere with reading the test. (Figure1) 
 Invalid test results 
1. The BLUE band (Control Line) is absent, with or without a visually 
detectable PINK-RED band (Test Line),  
2. A PINK-RED band appears at the letter “T” in the window after six 
minutes, or there is a line at this position of another colour other than pink-red, 
3. No Control Line band appears close to the letter “C”.  (The test is invalid 
since a shift in or absence of the control line indicates that the test procedure was 
performed improperly or that deterioration of the reagents has occurred.)   
If any test is difficult to interpret, the test should be repeated with the same sample to 
eliminate the potential for error.  Obtain a new sample and retest when the original sample 
repeatedly produces unreadable results. 
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Reporting of results 
 Negative for H. pylori 
 Report test result as: “H. pylori antigen is absent or below the level of detection.”   
 Positive for H. pylori 
  Report test result as: “H. pylori antigen detected.” 
Expected values 
Studies on the epidemiology of H. pylori have shown that this organism is present worldwide. 
Gastritis caused by H. pylori has been shown to correlate with age, ethnic background, family 
size and socioeconomic class.  The prevalence of H. pylori infection in a given population 
can vary from 20% to 90%.  In patients diagnosed with duodenal ulcers, however, it has been 
shown in every age group to be approximately 80%. Currently recommended eradication 
treatments have an efficacy rate between 75% and 90%. The ImmunoCard STAT HpSA test 
detects the presence of H. pylori antigens in human stool.   
Limitations of the test 
1. The test is qualitative and no quantitative interpretation should be made with respect to 
the intensity of the positive line when reporting the result. 
2. Test results are to be used in conjunction with information available from the patient 
clinical evaluation and other diagnostic procedures. 
3. Failure to add sufficient stool to the Specimen Diluent may result in a falsely negative 
test result.  Addition of too much stool may result in invalid test results due to the inhibition 
of proper sample flow. 
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4. Over incubation of tests may lead to false-positive test results.  Incubating tests at 
reduced temperatures or times may lead to falsely negative results. 
5. Performance characteristics have not been established for watery diarrheal stools.  
Watery stools composed mainly of fluid with little or no solid matter may give false negative 
test results. 
 
 
Figure 1 ImmunoCard STAT HpSA test results 
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Sample Size Calculations 
We based our sample size calculations assuming following parameters: alpha error = 0.5, power 
(beta error) = 0.90, Effect size (odds ratio) = 2.1, proportion of controls with the exposure = 0.40 
(H. pylori), proportion of cases with the exposure (H. pylori) = 0.50. The required sample size 
was 314 (157 cases and 157 controls). Based on the current literature and research conducted in 
India the average odds ratio addressing the relationship of H. pylori between peptic ulcer cases 
and controls was 4.2. We have utilized a much conservative OR in our sample size calculations. 
We created an MS access database for entering the data. The database was pilot tested in India 
and then revised to accommodate the suggestions by the RAs. 
Data Analysis 
The association between each potential risk factor and the outcome (H. pylori status, chronic 
gastric disease status, disease status) was measured using logistic regression models containing 
only the risk factors of interest. All risk factors associated with (H. pylori status, chronic gastric 
disease status, disease status) (at p < .10) were then entered into a multivariable logistic 
regression with backward elimination (p < .05 to retain) to select the final set of independent risk 
factors. The same multivariable model was chosen using a forward stepwise selection with an 
entry level p = .10 and a stay level p = .05. The multiple logistic regression model fit was 
determined by the Hosmer–Lemeshow test statistic. A model was considered a fit for the data if 
the Hosmer–Lemeshow statistics was with p value > .05. Continuous variables were checked in 
the models for linearity in the logic, using the method of fractional polynomials. We also check 
all the models for the presence of effect modification due to age and gender. Statistical analyses 
were conducted using SAS 9.1.3 (SAS Institute, Cary, NC, USA) and STATA 9.0 (STATA 
Corporation, College Station, TX, USA). All p-values are two-sided and a p < .05 was considered 
statistically significant.  
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Chapter Three 
Assessment of H. pylori prevalence and its risk factors among healthy individuals in 
Ecuador and Panama 
Background 
One of the most important virulence factors of H. pylori is CagA, which is located in the 
pathogenicity island region. [184] CagA is further classified into 2 major types, East-Asian type 
and Western type. The East-Asian type CagA is considered to be more virulent than the Western 
type by virtue of its more potent stimulation of host signal transduction pathways. [184] [186]  
Hence, many researchers have studied CagA genotype extensively from stomach biopsies of 
individuals suffering from gastric ailments. [184] [187, 188] However, since it is tedious to 
collect gastric biopsy samples from asymptomatic individuals, the genotype of the virulence 
factors of H. pylori isolated from asymptomatic people have been insufficiently analyzed, both 
qualitatively and quantitatively. [184] Analysis of H. pylori infection in asymptomatic people in 
areas with different prevalence of stomach cancer may provide important information regarding 
the possible factors contributing to the development of stomach cancer. [184] So, to assess the 
risk factor contributing to prevalence of H. pylori and its genotypes in healthy individuals in 
Ecuador and Panama we undertook a cross sectional study with following specific aims: 
1) To determine the prevalence of H. pylori among healthy individuals living in Ecuador and 
Panama 2) To determine the prevalence of  CagA positive H. pylori infection in healthy 
individuals in Ecuador and Panama and  3) To determine various risk factors for prevalence of H. 
pylori infection. 
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Methods 
The study was conducted in Ecuador and Panama from May 2007 to August 2007. All 
participants were screened for age and medical history in order to select asymptomatic adult 
individuals. Asymptomatic individuals were defined as those who have not had any subjective 
symptoms of gastric disorders or have not been diagnosed with any stomach diseases by a 
medical doctor within the last 6 months. Those individuals who had taken antibiotics within 6 
months were excluded. A total of 90 and 75 participants living in Ecuador and Panama, 
respectively, were enrolled in the study. All of the participants gave their informed consent. The 
research protocols were approved by the ethics committees of the University of South Florida 
(Tampa, FL), Universidad Central del Ecuador (Quito, Ecuador), and Gorgas de Estudios de la 
Salud (Panama City, Panama). 
We collected data on risk factors for H. pylori infection in one on one interview conducted by a 
bilingual (English-Spanish) interviewer using a structured questionnaire. H. pylori antigen 
(catalase) in stool specimens was detected using Testmate Rapid Pylori Antigen kit (BD, Tokyo, 
Japan) by following the manufacturer’s instructions. Briefly, a 20-mg stool specimen was taken 
and suspended in the sample dilution buffer. One drop of the stool suspension was utilized for the 
immunochromatography test. The reaction was carried out at room temperature for 10 min. H. 
pylori virulence factor cagA was genotyped by polymerase chain reaction. The identification of 
helminth was made morphologically following the guidelines of the American Society of 
Parasitology. The association between various risk factors and H. pylori status was analyzed by 
chi-square test or Fisher’s exact test. Statistical significance was set at P<0.05.  
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Results 
The demographic characteristics of 90 participants from Ecuador are listed in Table 2. There were 
68 (76%) study participants between 30 to 55 years of age. The number of females and males in 
the study were approximately equal (48 and 42 respectively). The percentage of participants who 
have primary or secondary school education was 69, while only 23% of the sample had university 
level education and 8% had a diploma. Majority (77%) of the subject’s ethnicity was Mestizo. 
Table 2 Demographic characteristic of the participants in Ecuador (n =90). 
Characteristics N (%) 
Age group 
     30-55 years 
     > 55 years 
 
68 (76) 
22 (24) 
Gender 
     Female 
     Male 
 
48 (53) 
42 (47) 
Education 
     Primary 
     High School 
     University 
     Other (diploma) 
 
36 (44) 
21 (25) 
21 (23) 
12   (8) 
Ethnicity 
     Mestizo 
     African descent 
     Spanish descent  
     Indian descent 
 
70 (77) 
6  (7) 
7  (8) 
7  (8)     
Length of stay at current residence      
     0.5-20 years 
     21-40 years 
     >40 years 
 
53 (59) 
27 (30) 
10 (11) 
  
The demographic characteristics of 75 participants from Panama are presented in Table 3. There 
were 34 (45%) study participants between 20 to 55 years of age. The number of females (37 %( 
28 /75)) were less compared to males (63 %( 47/75)). The percentage of participants who have 
primary or high school education was 84 (63/75), while only 16% (12/75) were uneducated. 
Majority (46% (32/75)) of the subject’s ethnicity was Spanish decent.  
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Table 3 Demographic characteristic of the participants in Panama (n= 75) 
Characteristics N (%) 
Age group 
     20-55 years 
     > 55 years 
 
34 (45) 
41 (55) 
Gender 
     Female 
     Male 
 
28 (37) 
47 (63) 
Education 
     None 
     Primary / High School     
 
12 (16) 
63 (84) 
Ethnicity 
     Mestizo 
     African descent 
     Spanish descent  
     Indian descent 
 
18 (26) 
  3 (4) 
32  (46) 
17  (24)     
Length of stay at current residence      
     0.5-20 years 
     21-40 years 
     >40 years 
 
8 (11) 
15 (20) 
52 (69) 
 
The frequency distribution of participant characteristics by three study sites in Ecuador in listed in 
Table 4. A total of 71% (65/90) of subjects were infected with H. pylori. These 65 subjects were 
evenly distributed over the three study regions. One third of our study participants had history of 
chronic gastric disease. We did not confirm this by examining the subject for diagnosis of chronic 
gastric disease in our study. The prevalence of intestinal parasitic infection and the drugs used for 
its treatment along with drugs used for general parasitic infection was similar in three study 
regions. We did not find any regional differences in the prevalence of protozoa infestation. But 
malaria was significantly associated with different regions (P-Value=0.00). Compared to cases of 
malaria in highlands of Quito, there were significantly higher number of cases in subtropical area 
of La Concordia and tropical Atacames. 
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Table 4: Frequency of study variables by regions in Ecuador 
Participant 
characteristics 
Quito  
N (%) 
La Concordia   
N (%) 
Atacames  
N (%) 
P-Value 
H. pylori 
     Positive  
     Negative 
 
20 (31) 
9   (36) 
 
23 (35) 
10 (40) 
 
22 (34) 
6   (24) 
 
0.66 
Gastric disease 
     Yes 
     No 
 
12 (39) 
17 (29) 
 
11 (36) 
22 (37) 
 
8   (25) 
20 (34) 
 
0.59 
Intestinal Parasite 
    Yes 
     No 
 
19 (34) 
10 (30) 
 
20 (35) 
13 (38) 
 
17 (31) 
11 (32) 
 
0.92 
Malaria 
     Yes 
     No 
 
3   (7) 
26  (59) 
 
26 (56) 
7   (16) 
 
17 (37) 
11  (25) 
 
0.00 
Anti parasitic drug use 
     Yes 
     No 
 
22 (30) 
7   (41) 
 
29 (40) 
4   (23) 
 
22 (30) 
6   (36) 
 
0.49 
Intestinal parasite drug 
use 
     Yes 
     No 
 
 
11 (35) 
18 (30) 
 
 
8 (26) 
25 (42) 
 
 
12 (39) 
16 (28) 
 
 
0.27 
Protozoa infestation 
     Yes 
     No 
 
9   (24) 
20 (38) 
 
17 (45) 
16 (31) 
 
12 (31) 
16 (31) 
 
0.26 
 
The relationship between selected participant characteristics and their H. pylori status in Ecuador 
are given in Table 5. Demographic characteristics such as gender, length of stay at current 
residence and age were not associated with H. pylori status. However, overall educational 
attainment was significantly associated with H. pylori status (P-Value=0.03). Participants who 
had lower education were more likely to have H. pylori infection compared to participants who 
had higher education. Study participant’s current tobacco use and the age at which they started 
smoking were not associated with H. pylori (P-Value=1.00 and 0.15 respectively). Amount of 
whiskey and beer consumption per day were not associated with H. pylori status (P-Value=0.17 
and 0.58). Prevalence of gastric disease was not associated with H. pylori status (P-Value=0.32). 
In this study, the amount of chili peppers consumed were not associated with H. pylori (P-
Value=0.34). Furthermore, anti-parasitic drug use and protozoa infestation were not associated 
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with H. pylori status (P-Value=1.00 and 0.81 respectively). 
Table 5: Relationship between participant characteristics and H. pylori in Ecuador 
 H. pylori  
Participant 
characteristics 
Present N 
(%) 
Absent N 
(%) 
P-Value 
Gender 
    Female 
    Male 
 
33 (69) 
32 (76) 
 
15 (31) 
10 (24) 
 
0.48 
Education 
     Primary School 
     High School 
     University 
     Other 
 
22 (61) 
19 (91) 
13 (62) 
11 (92) 
 
14 (39) 
2   (9) 
8   (38) 
1   (8) 
 
0.03 
Smoking Age 
     <20 years 
     21-35 years 
     >36 years 
 
24 (80) 
4   (44) 
37 (72) 
 
6   (20) 
5   (64) 
14 (28) 
 
0.15 
Alcohol amount 
(whiskey) 
     <= 50 mL / day 
     > 50 mL / day 
 
 
51 (76) 
14 (60) 
 
 
16 (24) 
9   (40) 
 
 
0.17 
Chili peppers amount 
  <= 1.5 chili peppers/day 
  > 1.5 chili peppers/day 
 
36 (68) 
29 (78) 
 
17 (32) 
8   (22) 
 
0.34 
Current Tobacco use 
     Yes 
     No 
 
30 (73) 
35 (71) 
 
11 (27) 
14 (29) 
 
1.00 
Beers per day 
     <= 1 can / bottle 
     2-4 cans / bottles 
     >= 5 cans / bottles 
 
39 (70) 
16 (80) 
10 (66) 
 
16 (30) 
4  (20) 
5  (34) 
 
0.58 
Gastric disease 
     Yes 
     No 
 
20 (65) 
45 (76) 
 
11 (35) 
14 (24) 
 
0.32 
Anti-parasitic drug use 
     Yes 
     No 
 
53 (73) 
12 (71) 
 
20 (27) 
5   (29) 
 
1.00 
Protozoa infestation 
     Yes 
     No 
 
28 (74) 
37 (71) 
 
10 (26) 
15 (29) 
 
0.81 
 
The relationship between selected participant characteristics and their H. pylori status in Panama 
are presented in Table 6. Demographic characteristics such as length of stay at current residence 
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and age were not associated with H. pylori status. However, male participants were more likely to 
have H. pylori infection compared to female participants (P-Value=0.05). Study participant’s 
smoking status and the age at which they started smoking were not associated with H. pylori (P-
Value=0.10). However, alcohol amount was associated with H. pylori status. Participants who 
were consuming more than 50ml of alcohol per day were more likely to have H. pylori infection 
compared to participants consuming 50ml or less alcohol per day.  (P-Value=0.02). Chronic 
gastric disease was not associated with H. pylori (P-Value=0.40).  The amount of chili peppers 
consumed were not associated with H. pylori (P-Value= 0.79). Furthermore, anti-parasitic drug 
use and protozoa infestation were not associated with H. pylori status (P-Value=0.23 and 1.00 
respectively).          
 Table 6: Relationship between participant characteristics and H. pylori in Panama 
Participant characteristics H. pylori 
Present N (%)   Absent N (%) 
P-Value 
Gender 
    Female 
    Male 
 
11 (39) 
30 (64) 
 
17 (61) 
17 (36) 
 
0.05 
Education 
     None 
     Primary 
     High School /  Technical     
 
 8 (67) 
31 (55) 
2  (29) 
 
4   (33) 
25 (45) 
5   (71) 
 
0.26 
Smoking  
     Yes 
      No 
 
20 (67) 
21 (47) 
 
10 (33) 
24 (53) 
 
0.10 
Alcohol amount 
     <= 50 mL / day 
     > 50 mL / day 
 
13 (39) 
28 (67) 
 
20 (61) 
14 (33) 
 
0.02 
Chili peppers amount 
  <= 1.5 chili peppers/day 
  > 1.5 chili peppers/day 
 
13 (59) 
28 (53) 
 
9 (41) 
25 (47) 
 
0.79 
Chronic gastric disease 
     Yes 
     No 
 
7 (44) 
34 (58) 
 
  9 (56) 
25 (42) 
 
0.40 
Anti-parasitic drug use 
     Yes 
     No 
 
25 (56) 
14 (54) 
 
20 (44) 
12 (46) 
 
0.23 
Protozoa infestation 
     Yes 
     No 
 
2 (50) 
39 (55) 
 
2 (50) 
32 (45) 
 
1.00 
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The relationship between participant characteristics and chronic gastric disease in Ecuador are 
presented in Table 7. Education and gastric disease were not associated with each other (P-
Value=0.13). The p-value suggests that education has a weak association with chronic gastric 
disease. Participants who had lower education were found to have chronic gastric disease 
compared to participants who had higher education. Antiparasitic drug use for intestinal parasites 
was associated with having chronic gastric disease (P-Value=0.06). Individuals having history of 
antiparasitic drugs use for intestinal parasites were found to have chronic gastric disease. 
Hypertension was significantly associated with having chronic gastric disease (P-Value=0.01). 
Hypertensive individuals seemed to have chronic gastric disease. Individuals who reported 
current medication use were also found to have chronic gastric disease (P-Value=0.08).  
Table: 7 Relationship between participant characteristics and chronic gastric disease in Ecuador 
Participant characteristics Chronic gastric disease 
Present N (%)  Absent N (%) 
P-Value 
Center 
     Quito 
     La Concordia 
     Atacames 
 
12 (41) 
11 (33) 
8 (29) 
 
17 (59) 
22 (67) 
20 (71) 
 
0.59 
Gender 
    Female 
    Male 
 
19 (40) 
12 (29) 
 
29 (60) 
30 (71) 
 
0.37 
Education 
     Primary School 
     High School 
     University 
     Other 
 
14 (38) 
9 (43) 
5 (25) 
0 (0) 
 
23 (62) 
12 (57) 
15 (75) 
7 (100) 
 
0.13 
First Food Choice 
     Vegetarian 
     Non-Vegetarian 
 
15 (45) 
16 (28) 
 
18 (55) 
41 (72) 
 
0.11 
Intestinal anti-parasitic drug 
use 
  Yes 
   No 
 
15 (48) 
16 (27) 
 
16 (52) 
43 (73) 
 
0.06 
Hypertension 
     Yes 
     No 
 
9 (64) 
22 (29) 
 
5 (36) 
54 (71) 
 
0.01 
Current Medication use 
     Yes 
     No 
 
13 (48) 
17 (28) 
 
14 (52) 
44 (72) 
 
0.08 
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Participant characteristics Chronic gastric disease 
Present N (%)  Absent N (%) 
P-Value 
 Beers per day 
     <= 1 can / bottle 
     2-4 cans / bottles 
     >= 5 cans / bottles 
 
24 (43) 
4 (20) 
3 (21) 
 
22 (57) 
16 (80) 
11 (79) 
 
0.11 
Alcohol consumption 
     <= 1 drink/month 
     > 1 drinks/month 
     Everyday    
 
27 (38) 
3 (17) 
1 (50) 
 
43 (62) 
15 (83) 
1 (50) 
 
0.15 
 
The relationship between selected participant characteristics and chronic gastric disease in 
Panama is listed in Table 8. Education, gender and ethnicity were not associated with chronic 
gastric disease. Similarly, alcohol amount and amount of chili peppers consumed were not 
associated with chronic gastric disease. However, smoking status was associated with chronic 
gastric disease (P-Value=0.04). Antiparasitic drug use and protozoa infestation were not 
associated with chronic gastric disease. 
Table: 8 Relationship between participant characteristics and chronic gastric disease in Panama 
Participant 
characteristics 
 
Chronic gastric disease 
Present N (%)   Absent N (%) 
P-Value 
Gender 
    Female 
    Male 
 
4  (14) 
12 (25) 
 
24 (86) 
35 (75) 
 
0.38 
Education 
     None 
     Primary 
     High School / Technical     
 
4 (33) 
10 (18) 
2 (29) 
 
8 (67) 
46 (82) 
5 (71) 
 
0.43 
Ethnicity 
     Mestizo 
     African descent 
     Spanish descent  
     Indian descent 
 
0 (0) 
1 (33) 
8 (25) 
6 (35) 
 
18 (100) 
2 (67) 
24 (75) 
11 (65) 
 
0.06 
Smoking  
     Yes 
      No 
 
10 (33) 
6   (13) 
 
20 (67) 
39 (87) 
 
0.04 
Alcohol amount 
     <= 50 mL / day 
     > 50 mL / day 
 
5   (15) 
11 (26) 
 
28 (85) 
31 (74) 
 
0.27 
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Participant 
characteristics 
 
Chronic gastric disease 
Present N (%)   Absent N (%) 
P-Value 
Chili peppers amount 
  <= 1.5 chili peppers/day 
  > 1.5 chili peppers/day 
 
5  (23) 
11 (21) 
 
17 (73) 
42 (79) 
 
1.00 
Anti-parasitic drug use 
     Yes 
     No 
 
25 (56) 
14 (54) 
 
20 (44) 
12 (46) 
 
0.23 
Protozoa infestation 
     Yes 
     No 
 
10 (22) 
5   (19) 
 
35 (73) 
21 (81) 
 
1.00 
 
Assessment of H. pylori antigen in the stool specimens obtained from participants revealed an H. 
pylori infection rate of 72% in Ecuador, and that this positive rate was significantly higher than 
the rate detected in Panama (54%) (Figure 2).   
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Ecuador (N = 90)
Number of positive / Number 
tested (%)
H pylori antigen test:
65/90 (72%)
H pylori gene detection:
61/65 (94%)
cag A status:
28/61 (46%)
East Asian cagA status:
25/28 (89%)
Panama (N= 74)
Number of positive / Number 
tested (%)
H pylori antigen test:
40/74 (54%)
H pylori gene detection:
35/40 (87%)
cag A status:
7/35 (20%)
East Asian cagA status:
7/7 (100%)
P value = 0.01
P value = 0.29
P value = 0.01
P value = 1.00
 
Figure 2 H. pylori genotype assessment 
Bacterial DNA was extracted from H. pylori antigen-positive stool specimens and the extracted 
DNA was subjected to PCR for the detection of H. pylori genes. The H. pylori 16S rRNA gene 
was detected by real-time PCR for confirmation of the existence of H. pylori DNA in the 
extracted DNA. As shown in Figure 1, H. pylori genes were detected in 94% of H. pylori 
antigen-positive Ecuador specimens and in 87% of the Panama specimens.[182] 
The CagA gene was detected in 46% and 20% of the H. pylori DNA-positive specimens from 
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Ecuador and Panama, respectively, and this difference was demonstrated to be statistically 
significant (Figure 1). Furthermore, analysis of the CagA genotype revealed that the East-Asian 
type was predominant in both countries (89% in Ecuador and 100% in Panama) (Figure 1).[182] 
Discussion: 
This was the first study to document the prevalence of H. pylori among healthy individuals in 
Ecuador and Panama.  Previously, it was reported that the prevalence of H. pylori infection in 
dyspeptic patients in Ecuador was 89.5% [189] and 79.6% to 82.9% in patients with chronic 
dyspepsia, gastric or duodenal ulcer, gastritis, or gastric cancer in Panama. [190-192] The results 
obtained in the present study are slightly lower than the published data for patients with chronic 
gastric disease in Ecuador and Panama. However, the infection rates in our study are higher than 
those in Western countries (32.7% in the United States, 25.4% in France, and 39.2% in 
Germany), which have a lower incidence of gastric cancer. [66] The reasons for the high H. 
pylori infection rates in asymptomatic people in both Ecuador and Panama are not clear. It is 
speculated that the poor public health conditions in both countries may be a contributory factor in 
the facilitating transmission of H. pylori.  
We hypothesize that certain prevalent food habits such as pre mastication of food by parents 
while feeding infants (person to person transmission via saliva) [193], consumption of restaurant 
food and possible contaminated water consumption (feco-oral transmission) might explain the 
high prevalence of H. pylori in Ecuador and Panama. In Ecuador and Panama the drinking water 
is chlorinated but the wastewater is not treated and is used for irrigation. Some researchers have 
recently shown that H. pylori can thrive in a non culturable coccoid form in biofilms even after 
chlorination. [194-197] Hence H. pylori may be able to tolerate disinfectants in distribution 
systems and, therefore, may be transmitted by a waterborne route. 
The detection of CagA in extracted DNA revealed that 46% of H. pylori DNA-positive samples 
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were CagA-positive in Ecuador, but that only 20% of similar samples were CagA-positive in 
Panama. Thus, a significant number (28%) of asymptomatic people in Ecuador are infected with 
the more pathogenic East-Asian genotype CagA-positive H. pylori. We hypothesize that this 
might be due to the racial differences between people from Ecuador and Panama. The high 
incidence rate of gastric cancer in Ecuador (24 per 100,000) compared to Panama (11.6 per 
100,000) can be attributed to these differences in CagA positive H. pylori prevalence.[198]    
The results obtained in the present study indicated that the methodology used is suitable for 
assessing the status of H. pylori infection in asymptomatic people. In addition, these results sug-
gested that the prevalence of H. pylori infection and/or the occurrence of CagA in the H. pylori 
detected in asymptomatic people may be related to the risk of stomach cancer.  
Most of the risk factors of interest were not significantly associated with H. pylori and chronic 
gastric disease. Our study concluded that gender was not associated with either H. pylori or 
history of gastric disease for a long duration. This finding is consistent with studies done in India 
and Northwest region of Ethiopia. [199-201] Education attainment was weakly associated with 
chronic gastric disease. However the contingency table analysis suggested that chronic gastric 
disease was more prevalent among participants having primary school education than participants 
having secondary school education and higher. In case of H. pylori prevalence; primary educated 
individuals had fewer than expected H. pylori cases than university level education. But at the 
same time we found that secondary level educated individuals had higher than expected H. pylori 
prevalence. This finding is not consistent with studies done in Saudi Arabia and Brazil where 
lower education was associated with high prevalence of H. pylori. [81, 202-207] 
So far in many of the studies published we found that H. pylori incidence was increasing with 
age. In our study age not associated with H. pylori. (P value = 1.00) Our finding is not consistent 
with other studies probably due to the small sample size (n = 90) Owing to our inclusion criteria 
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the youngest participant in our study was 39 years old. After categorizing the participant’s age 
into only two groups we did not find any association with H. pylori.  
Tobacco and alcohol use was found to be associated with H. pylori in many of the studies 
published so far. [74, 130, 208-210] In our study the current tobacco use, age at which the 
participant’s started to smoke cigarettes and alcohol consumption (whiskey, beer and home-made 
alcohol) was not associated with H. pylori status. 
Dietary choices such as being vegetarian and eating chili peppers were not associated with H. 
pylori status (P value ≥ 0.10). Anti-parasitic drug use and protozoa infestation were not associated 
with H. pylori status. 
Entamoeba coli was the most prevalent infection (n=20) followed by Entomeba Histolytica (n = 
13). Eight study participants were found to have Endolimax nana infection where as only six 
study participants were found infected with Blastocistis Hominis.                
In this cross sectional study we used prevalence of chronic gastric disease as a surrogate measure 
of gastric pathology in general. In this study we tried to shed more light on the relationship 
between gastric disease and risk factors such as education, spicy food consumption, consumption 
of high temperature food, intestinal parasite drug use, and hypertension. These risk factors were 
associated with having chronic gastric disease. 
Our study had some limitations. This was a cross sectional study. Hence we did not expect to 
prove cause – effect relationship between various risk factors of H. pylori and its prevalence. 
Owing to the financial constraints we recruited ninety participants from three areas of Ecuador. 
During the data analysis; as evident from the contingency tables overview this sample of ninety 
individuals proved to be small as most of the variables that we assessed were having cell size less 
than five. Overall the power of the Fisher exact test used to test the association between risk 
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factors and H. pylori was poor (power = 0.20). We collected information regarding history of 
chronic gastric disease. In our data analysis we have used chronic gastric disease as an indicator 
variable for gastric pathology. One of the study aims was to elucidate the relationship between 
helminth and H. pylori co-infection. We collected the stool specimens from all the study 
participants and we analyzed it for presence of helminthes. Only one study participant was 
diagnosed to have a helminth infection (Strongloydes stercolis). Our study participants were from 
a lower / moderate socio-economic status; we believe that the data we have is an indicator of the 
success of the mass de-worming campaign implemented by the government of Ecuador. 
Based on above mentioned limitations and findings we revised the data collection instrument and 
study design to conduct a hospital based case control study in India. 
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Chapter Four 
Assessment of risk factors for peptic ulcer and gastric cancer along with Helicobacter pylori 
infection in India 
Background 
It is estimated that the gastric pathogen Helicobacter pylori (H. pylori), first isolated in 1982 by 
Warren and Marshall, infects more than 50% of the world’s population. [130, 211-214] The 
infection is usually acquired in childhood, with low socioeconomic status being associated with a 
high prevalence of infection. There is variation in the prevalence of H. pylori among various 
countries in the world. [38, 128, 130, 211, 214-217] Previous studies from India have reported a 
high, at times as high as 80% prevalence of H. pylori in India. [66] Peptic ulcer disease is 
frequent in India but there is paucity of data on its prevalence.[41, 218] The prevalence of peptic 
ulcer is noted to be on average around 8.0 per 100,000 in India. [41] The age adjusted incidence 
rate of gastric cancer in urban registries in India is reported in the range of 3.0 per 100,000 which 
is on the lower side among those reported worldwide (14 per 100,000). [219] Previous Indian 
studies on the prevalence of peptic ulcer were not community based and may have been subject to 
selection bias. Indeed, some researchers have noted the association between H. pylori infection 
and peptic ulcer in India but at times no association between stomach cancer and H. pylori 
infection. [31, 220-224] However, these studies are criticized to have small sample size and 
inadequate methodological details such as inadequate description of sample size calculations, 
case definitions etc. [35, 225-227] Nonetheless, no studies have been conducted in Western India 
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enrolling adequate number of patients and having sound methodological quality to assess the 
relationship between peptic ulcer and H. pylori and their various risk factors. Indeed, some 
researchers have noted that apart from the virulent genotype of H. pylori environmental and 
dietary factors influence the outcome of disease. [117, 221, 228, 229]  However, these risk factors 
for prevalence of H. pylori especially the environmental and dietary factors in Indian context 
have received minimal attention.  
Hence to address these issues we conducted a case control study in Pune, Maharashtra, India with 
following specific aim. 1) To determine various risk factors for peptic ulcer, stomach cancer and 
prevalence of H. pylori infection in Pune, India. 
Methods 
We conducted our study at Pune city in the state of Maharashtra in India at Deenanath 
Mangheskar Hospital and Research Center (DMH) between Spring 2008 – Fall 2010. Our 
hospital based case control study had three groups: 1) peptic ulcer patients 2) stomach cancer 
patients 3) controls. The peptic ulcer and stomach cancer cases were identified via the DMH 
database using the ICD10 coding. Any patient more than 18 years of age and listed in the DMH 
database as having diagnosis of either peptic ulcer or stomach cancer was eligible for enrollment. 
We also followed a cohort of H. pylori positive patients (n =100) during their first visit to DMH. 
We enrolled consecutive patients with H. pylori positive patients during their first visit to DMH 
until we accrued 100 patients.  
We collected data on risk factors for H. pylori infection in one on one participant interview. All 
interviews were conducted by the bilingual (English – Marathi) speaking native study research 
associates (RA). H. pylori antigen in stool specimens was detected using ImmunoCard STAT 
HpSA antigen detection kit by following the manufacturer’s instructions. (Meridian Diagnostics, 
Inc, USA). Briefly, a small portion (5-6 mm diameter) of stool specimen was transferred into the 
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sample diluent vial using the applicator stick, vortexed for 15 s, and then 4 drops were dispensed 
into the round window at the lower end of the device. The results were read 5 min later.  
We based our sample size calculations assuming following parameters: alpha error = 0.5, power 
(beta error) = 0.90, Effect size (odds ratio) = 2.1, proportion of controls with the exposure = 0.40 
(H. pylori), proportion of cases with the exposure (H. pylori) = 0.50). The association between 
each potential risk factor and the outcome (H. pylori status, chronic gastric disease status, disease 
status) was measured using logistic regression models containing only the risk factors of interest. 
All p-values are two-sided and a p < .05 was considered statistically significant. We obtained the 
approval for this project from the institutional review board at University of South Florida and 
from the DMH ethics committee. 
Results: 
We contacted a total of 491 potential participants. We were able to enroll 190 patients diagnosed 
with peptic ulcer and only 35 patients diagnosed with stomach cancer. We then were able to 
enroll 125 controls in our study. (Figure 3) 
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Total cases screened  for 
enrollment in the study
N = 296
Total cases NOT eligible  
for enrollment in the study
N = 35
Total cases who didn’t 
submit the stool sample
N = 36
Total cases enrolled in 
the study
N = 225
Total peptic ulcer cases 
enrolled in the study
N = 190
Total stomach cancer 
cases enrolled in the 
study
N = 35
Total controls screened  
for enrollment in the study
N = 195
Total controls NOT 
eligible  for enrollment in 
the study
N = 25
Total controls who didn’t 
submit the stool sample
N = 45
Total controls enrolled in 
the study
N = 125
 
Figure 3 Study participant recruitment flow chart 
The median age of the enrolled participants was 56 years (range: 18 – 83 years). Fifty three 
percent (187/350) of participants were females while 47% (163/350) were males. Forty percent 
(139 /350) of participants had primary education while 32% (111/350) had completed high 
school. Only 29% (100/350) of participants had university level education. (Table 9) 
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Table 9   Demographic characteristics of study participants Pune, India 
Characteristics N (%) 
Disease  
Controls 
Peptic ulcer 
Stomach cancer 
 
125 (36) 
190 (54)  
  35 (10) 
Median age (Range)  56 years (range:18-83) 
Gender 
     Female 
     Male 
 
187 (53) 
163 (47) 
Education 
     Primary School 
     High School 
     University      
 
139 (40) 
111 (32) 
100 (29) 
 
In the initial univariate analysis, demographic characteristics such as gender (P-Value=0.74), 
education (P-Value=0.12), age were not associated with H. pylori status. Study participant’s 
disease status (having peptic ulcer versus not having any gastric ailment) was associated with H. 
pylori (P-Value=0.00). Study participant’s current tobacco use was associated with H. pylori (P-
Value=0.01). Participants’ consumption of snacks while drinking alcohol was not associated with 
H. pylori status (P-Value=0.10). However, consumption of chili peppers (P-Value=0.00) and 
meat (P-Value=0.02) had a statistically significant association with H. pylori status. But, fish 
consumption (P-Value=0.31) and consuming the food items while they were hot (in terms of food 
temperature) (P-Value=0.07) were not associated with H. pylori status. Interestingly, frequency of 
outside food consumption was highly associated with H. pylori status (P-Value=0.00). The 
participant’s chronic gastric status (P-Value=0.00) and its frequency (P-Value=0.02) were 
associated with their H. pylori status. Similarly, family history of peptic ulcer was associated with 
H. pylori status (P-Value=0.00). Moreover, parasite (P-Value=0.00) and protozoa infestations (P-
Value=0.02) were associated with H. pylori status. But, helminth infection was not associated 
with H. pylori status (P-Value=0.55). However, anti parasitic drug use was associated with H. 
pylori status (P-Value=0.04). But, prior treatment of H. pylori was not associated with current H. 
pylori status (P-Value=0.80). Participant’s H. pylori status was associated their spouses’ H. pylori 
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infection status (P-Value=0.00). (Table 10) 
The final multivariate logistic regression analysis results for the association of participant 
characteristics and H. pylori status are shown in Table 11. As noted in the univariate analysis, the 
SES as indicated by the car ownership remained associated with H. pylori status in the 
multivariate analysis (OR: 1.10 95%CI: 1.02-1.39). Prevalence of H. pylori was highly associated 
with chronic gastric ailments. (OR: 3.73 95%CI: 1.69-8.26). Smoking was also highly associated 
with prevalence of H. pylori in this population (OR: 2.23 95%CI: 1.24-4.02). Similarly, 
consumption of meat was a high risk factor of H. pylori infection (OR: 2.35 95%CI: 1.30-4.23). 
As seen in the univariate analysis consumption of chili peppers was an important protective factor 
against H. pylori infection (OR: 0.20 95%CI: 0.10-0.37). Drinking filtered or boiled water versus 
non filtered or boiled water use was associated with H. pylori status. (OR: 1.05 95%CI: 1.01-
1.23). Consumption of restaurant food was also associated with prevalence of H. pylori. (Table 
11) 
Table 10: Relationship between participant characteristics and H. pylori in Pune, India 
Participant 
characteristics 
 
H. pylori (n= 350) 
Present N (%)         Absent N (%) 
Univariate  
P-Value 
Gender 
    Female 
    Male 
 
98 (52) 
82 (50) 
 
89 (48) 
81 (50) 
 
0.74 
Education 
     Primary School 
     High School 
     University 
 
78 (56) 
59 (53) 
43 (43) 
 
61 (54) 
52 (47) 
57 (57) 
 
0.12 
Car ownership  
     Yes 
     No 
 
99 (45) 
81 (61) 
 
118 (55) 
52   (39) 
 
0.00 
Drinking water  
     Filtered / boiled 
     Not filtered / boiled 
 
104 (45) 
76   (63) 
 
125 (55) 
45   (37) 
 
0.00 
Disease status 
Peptic ulcer 
Stomach cancer 
Controls 
 
115 (61) 
8     (23) 
57   (46) 
 
75 (39) 
27 (77) 
68 (54) 
 
0.00 
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Participant 
characteristics 
 
H. pylori (n= 350) 
Present N (%)         Absent N (%) 
Univariate  
P-Value 
Smoking  
     Yes 
     No 
 
110 (57) 
  70 (44) 
 
82 (43) 
88 (56) 
 
0.01 
Snack with Alcohol  
    Yes 
    No  
    Not applicable 
 
69 (57) 
35 (56) 
76 (46) 
 
52 (43) 
27 (44) 
91 (54) 
 
0.10 
Chili  pepper Consumption 
    Yes 
     No 
 
87 (42) 
93 (66) 
 
122 (58) 
48   (34) 
 
0.00 
Meat Consumption 
     Yes 
     No 
 
87 (61) 
93 (45) 
 
55   (39) 
115 (55) 
 
0.00 
Fish Consumption 
     Yes 
     No 
 
52   (56) 
128 (50) 
 
41   (44) 
129 (50) 
 
0.31 
Consumption of food 
while it is hot 
     Yes 
     No 
 
 
90   (57) 
90   (47) 
 
 
68   (43) 
102 (53) 
 
 
0.07 
Frequency of outside food 
consumption  
     Almost never 
     1 / week 
     2 / week 
     3 / week 
 
 
99 (42) 
18 (56) 
32 (76) 
31 (77) 
 
 
137 (58) 
14   (44) 
10   (24) 
9     (23) 
 
 
0.00 
Chronic gastric disease 
     Yes 
     No 
 
127 (59) 
53   (40) 
 
89 (41) 
81 (60) 
 
0.00 
Frequency of gastric 
disease 
     Never 
     1 /month 
     1 /week 
  ≥ 2 / week 
 
 
76 (46) 
52 (67) 
33 (47) 
19 (50) 
 
 
88 (54) 
26 (33) 
37 (53) 
19 (50) 
 
 
0.02 
Family history of  ulcer 
     Yes 
     No 
 
62   (63) 
118 (47) 
 
37   (37) 
133 (53) 
 
0.00 
Parasite infestation 
     Yes 
     No 
 
69   (42) 
111 (59) 
 
94 (58) 
76 (41) 
 
0.00 
Protozoa infestation 
     Yes 
     No 
 
86 (46) 
94 (58) 
 
102 (54) 
68   (42) 
 
0.02 
Helminth infestation 
     Yes 
     No 
 
46   (48) 
134 (53) 
 
49   (52) 
121 (47) 
 
0.55 
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Participant 
characteristics 
 
H. pylori (n= 350) 
Present N (%)         Absent N (%) 
Univariate  
P-Value 
Anti-parasitic drug use 
     Yes 
     No 
 
107 (57) 
73   (45) 
 
82 (43) 
88 (55) 
 
0.04 
H. pylori treatment kit 
used 
     Yes 
     No 
 
 
46   (50) 
134 (52) 
 
 
46   (50) 
124 (48) 
 
 
0.80 
Spouses’ H. pylori 
infection status 
     Yes 
     No 
     Don’t know 
 
 
  29 (78) 
  40 (75) 
111 (43) 
 
 
   8  (22) 
  13 (25) 
149 (57) 
 
 
0.00 
 
Table 11: Multivariate model: Relationship between participant characteristics and H. pylori In 
Pune, India 
Participant 
characteristics 
Adjusted 
Odds ratio 
95% Confidence 
interval 
P value 
Car ownership 
     Yes 
     No 
 
1 
1.10 
 
 
1.02 – 1.39 
 
 
0.05 
Parasite infestation 
     Yes 
No 
 
0.44 
1 
 
0.24 – 0.80 
 
0.00 
Chronic gastric disease 
    Yes 
    No     
 
3.73 
1 
 
1.69 – 8.26 
 
 
0.00 
Chili pepper 
Consumption 
     Yes 
     No 
 
 
0.20 
1 
 
 
0.10 – 0.37 
 
 
0.00 
Meat Consumption 
     Yes 
     No 
 
2.35 
1 
 
1.30 – 4.23 
 
0.00 
Smoking  
    Yes 
    No     
 
2.23 
1 
 
1.24 - 4.02 
 
 
0.00 
Eating outside 
3 / week 
2 / week 
1 / week 
Almost never 
 
3.77 
2.69 
1.61 
1 
 
1.39 - 10.23 
1.18 -  7.42 
0.65 – 3.98 
 
0.01 
Water source 
     Filtered / boiled 
     Not filtered / boiled 
 
1 
1.05 
 
 
1.01 – 1.23 
 
 
0.05 
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We could enroll only 35 gastric cancer patients in this study. Also, the probability of H. pylori 
thriving in the stomach lining with the metaplasia is low. Hence due to their inadequate sample 
size and to avoid bias, we have eliminated these 35 patients from the analysis investigating 
association between participants’ disease status and various risk factors. 
In the initial univariate analysis, demographic characteristics such as gender (P-Value=0.42), 
education (P-Value=0.23), age were not associated with disease status. Study participant’s 
disease status (having peptic ulcer versus not having any gastric ailment) was associated with H. 
pylori (P-Value=0.01). Study participant’s current tobacco use was not associated with disease 
status (P-Value=0.16). Participants’ consumption of snacks while drinking alcohol was associated 
with disease status (P-Value=0.00). Consumption of chili peppers (P-Value=0.06) did not have a 
statistically significant association with disease status. But, consuming the food items while they 
were hot (in terms of food temperature), meat (P-Value=0.02) and fish (P-Value=0.01) was 
associated with disease status (P-Value=0.04). Frequency of outside food consumption was not 
associated with disease status (P-Value=0.30). Participants’ Family history of peptic ulcer was 
associated with disease status (P-Value=0.04). Parasite (P-Value=0.56), protozoa (P-Value=0.20) 
and helminth (P-Value=0.25) infestations were not associated with disease status. Prior treatment 
of H. pylori was associated with current disease status (P-Value=0.03). Participant’s disease 
status was associated their spouses’ H. pylori infection status (P-Value=0.00). (Table 12) 
The final multivariate logistic regression analysis results for the association of participant 
characteristics and disease status are shown in Table 13. As noted in the univariate analysis, 
participants H. pylori status remained associated with disease status in the multivariate analysis 
(OR: 1.70 95%CI: 1.03-2.89). Participants disease status was associated with consumption of 
meat (OR: 1.10 95%CI: 1.02-1.75). Similarly, participants disease status was associated with 
consumption of fish (OR: 1.05 95%CI: 1.02-1.89). Similarly, participants’ positive family history 
of ulcer was a risk factor of their peptic ulcer status (OR: 1.20 95%CI: 1.08-1.60). As seen in the 
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univariate analysis history of anti parasite drug use was an important protective factor against 
peptic ulcer prevalence (OR: 0.51 95%CI: 0.30-0.86). Similarly, consumption of snacks with 
alcohol remained an important protective factor against peptic ulcer in this study population (OR: 
0.32 95%CI: 0.13-0.78). (Table 13) 
Table 12: Relationship between participant characteristics and disease status (peptic ulcer vs. 
control) in Pune, India 
Participant 
characteristics 
Disease status (n = 315) 
Control N (%)    Peptic ulcer N (%) 
Univariate 
P-Value 
Gender 
    Female 
    Male 
 
62 (37) 
63 (42) 
 
104 (63) 
86 (53) 
 
0.42 
Education 
     Primary School 
     High School 
     University 
 
45 (35) 
40 (41) 
40 (46) 
 
85 (65) 
58 (59) 
47 (54) 
 
0.23 
H. pylori status 
Positive 
Negative 
 
57 (33) 
68 (47) 
 
115 (67) 
75   (52) 
 
0.01 
Smoking  
     Yes 
     No 
 
63 (36) 
62 (44) 
 
112 (64) 
78   (56) 
 
0.16 
Snack with Alcohol  
    Yes 
    No  
    Not applicable 
 
44 (39) 
9   (17) 
72 (48) 
 
68 (61) 
45 (83) 
77 (52) 
 
0.00 
Chili peppers Consumption 
    Yes 
     No 
 
 
65 (35) 
60 (46) 
 
 
119 (65) 
71   (54) 
 
0.06 
Meat Consumption 
     Yes 
     No 
 
45   (39) 
80   (42) 
 
94   (61) 
96   (58) 
 
0.02 
Fish Consumption 
     Yes 
     No 
 
11   (12) 
114 (51) 
 
78   (88) 
112 (49) 
 
0.01 
Consumption of food while 
it is hot 
     Yes 
     No 
 
 
50 (34) 
75 (45) 
 
 
99 (66) 
91 (55) 
 
 
0.04 
Outside food consumption  
     Almost never 
     1 / week 
     2 / week 
     3 / week 
 
90 (43) 
12 (39) 
13 (32) 
10 (29) 
 
119 (57) 
19 (61) 
28 (68) 
24 (71) 
 
0.30 
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Participant 
characteristics 
Disease status (n = 315) 
Control N (%)    Peptic ulcer N (%) 
Univariate 
P-Value 
Family history of  ulcer 
     Yes 
     No 
 
31 (31) 
94 (44) 
 
68   (69) 
122 (56) 
 
0.04 
Parasite infestation 
     Yes 
     No 
 
55 (38) 
70 (41) 
 
91 (62) 
99 (59) 
 
0.56 
Protozoa infestation 
     Yes 
     No 
 
61 (36) 
64 (44) 
 
107 (64) 
83   (56) 
 
0.20 
Helminth infestation 
     Yes 
     No 
 
30 (34) 
95 (42) 
 
58   (66) 
132 (58) 
 
0.25 
H. pylori treatment kit used 
     Yes 
     No 
 
 
42 (49) 
83 (36) 
 
 
43   (51) 
147 (64) 
 
 
0.03 
Spouses’ H. pylori 
infection status 
     Yes 
     No 
     Don’t know 
 
 
  25 (68) 
  0   (0) 
100 (43) 
 
 
  12 (32) 
  43 (100) 
135 (57) 
 
 
0.00 
 
Table 13: Multivariate model: Relationship between participant characteristics and disease status 
(peptic ulcer vs. control) in Pune , India 
Participant 
characteristics 
Adjusted 
Odds ratio 
95% Confidence 
interval 
P value 
H. pylori status 
Positive 
Negative 
 
1.70 
1 
 
1.03 – 2.89 
 
0.04 
Snack with Alcohol  
    Yes 
    No     
 
0.32 
1 
 
0.13 - 0.78 
 
 
0.00 
Meat Consumption 
     Yes 
     No 
 
1.10 
1 
 
1.02 – 1.75 
 
0.05 
Fish Consumption 
     Yes 
     No 
 
1.05 
1 
 
1.02 – 1.89 
 
0.05 
Family history of  
ulcer 
     Yes 
     No 
 
1.20 
1 
 
1.08 – 1.60 
 
0.04 
Anti-parasitic drug 
use 
     Yes 
     No 
 
0.51 
1 
 
0.30 - 0.86 
 
 
0.01 
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In this study we used prevalence of chronic gastric disease as a surrogate measure of gastric 
pathology in general. In this study we tried to shed more light on the relationship between gastric 
disease and risk factors such as education, spicy food consumption, consumption of high 
temperature food, intestinal parasite drug use, etc.  
In the initial univariate analysis, demographic characteristics such as gender (P-Value=0.80), 
education (P-Value=0.10), age were not associated with chronic gastric disease status. Study 
participant’s disease status (having peptic ulcer or stomach cancer versus not having any of these 
gastric ailments) was associated with chronic gastric disease (P-Value=0.03). Study participant’s 
H. pylori status was associated with chronic gastric disease (P-Value=0.00). Study participant’s 
current tobacco use was not associated with chronic gastric disease (P-Value=0.58). Participants’ 
consumption of snacks while drinking alcohol was not associated with chronic gastric disease 
status (P-Value=0.73). However, consumption of meat (P-Value=0.04) and fish (P-Value=0.03) 
had a statistically significant association with chronic gastric disease status. But, chili peppers 
consumption (P-Value=0.57) was not associated with chronic gastric disease status. However, 
consuming the food items while they were hot (in terms of food temperature) was associated with 
chronic gastric disease status (P-Value=0.00). Interestingly, frequency of outside food 
consumption was not associated with chronic gastric disease (P-Value=0.67). Family history of 
peptic ulcer was associated with chronic gastric disease status (P-Value=0.00). Parasite (P-
Value=0.23), protozoa (P-Value=0.51) and helminth infestations (P-Value=0.34) were not 
associated with chronic gastric disease status. (Table 14) 
The final multivariate logistic regression analysis results for the association of participant 
characteristics and chronic gastric disease status are shown in Table 15. As noted in the univariate 
analysis, participants H. pylori status remained strongly associated with chronic disease status in 
the multivariate analysis (OR: 2.48 95%CI: 1.24-4.96). Participants chronic gastric disease status 
was highly associated with consumption of meat (OR: 1.05 95%CI: 1.03-1.78). Similarly, 
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participants disease status was highly associated with consumption of fish (OR: 1.09 95%CI: 
1.06-1.90). Similarly, participants’ positive family history of ulcer was a high risk factor of their 
chronic disease status (OR: 4.45 95%CI: 1.95-10.15). As seen in the univariate analysis history of 
anti parasite drug use was a protective factor against peptic ulcer prevalence (OR: 0.43 95%CI: 
0.21-0.89). (Table 15) 
Table 14: Relationship between participant characteristics and chronic gastric disease status in 
Pune, India 
Participant 
characteristics 
 
Chronic gastric disease (n=350) 
Present N (%)        Absent N (%) 
Univariate 
P-Value 
Gender 
    Female 
    Male 
 
114 (61) 
102 (63) 
 
73 (39) 
61 (37) 
 
0.82 
Education 
     Primary School 
     High School 
     University 
 
90 (65) 
73 (66) 
53 (53) 
 
49 (35) 
38 (34) 
47 (47) 
 
0.10 
Disease status 
Peptic ulcer 
Stomach cancer 
Controls 
 
126 (66) 
15   (43) 
75   (60) 
 
64 (34) 
20 (57) 
50 (40) 
 
0.03 
H. pylori status 
Positive 
Negative 
 
127 (70) 
89   (52) 
 
53 (30) 
81 (48) 
 
0.00 
Smoking  
     Yes 
     No 
 
121 (63) 
  95 (60) 
 
71 (37) 
63 (40) 
 
0.58 
Snack with Alcohol  
    Yes 
    No  
    Not applicable 
 
78   (65) 
38   (61) 
100 (60) 
 
43 (35) 
24 (39) 
67 (40) 
 
0.73 
Chili peppers  
Consumption 
    Yes 
     No 
 
126 (60) 
90   (64) 
 
83 (40) 
51 (36) 
 
0.57 
Meat Consumption 
     Yes 
     No 
 
97  (68) 
119 (57) 
 
45 (31) 
89 (43) 
 
0.04 
Fish Consumption 
     Yes 
     No 
 
72   (88) 
144 (56) 
 
21   (22) 
113 (44) 
 
0.03 
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Participant 
characteristics 
 
Chronic gastric disease (n=350) 
Present N (%)        Absent N (%) 
Univariate 
P-Value 
Consumption of food 
while it is hot 
     Yes 
     No 
 
 
116 (73) 
100 (52) 
 
 
42 (27) 
92 (48) 
 
 
0.00 
Frequency of outside 
food consumption  
     Almost never 
     1 / week 
     2 / week 
     3 / week 
 
 
141 (60) 
21 (66) 
29 (69) 
25 (63) 
 
 
95 (40) 
11 (34) 
13 (31) 
15 (37) 
 
 
0.67 
Family history of  
ulcer 
     Yes 
     No 
 
84   (85) 
132 (53) 
 
15   (15) 
119 (47) 
 
0.00 
Parasite infestation 
     Yes 
     No 
 
95   (58) 
121 (65) 
 
68 (42) 
66 (35) 
 
0.23 
Protozoa infestation 
     Yes 
     No 
 
113 (60) 
103 (64) 
 
75 (40) 
59 (36) 
 
0.51 
Helminth infestation 
     Yes 
     No 
 
63   (66) 
153 (60) 
 
32   (34) 
102 (40) 
 
0.34 
 
Table 15: Multivariate model: Relationship between participant characteristics and chronic gastric 
disease in Pune, India  
Participant 
characteristics 
Adjusted 
Odds ratio 
95% Confidence 
interval 
P value 
H. pylori status 
Positive 
Negative 
 
2.48 
1 
 
1.24 – 4.96 
 
0.00 
Meat Consumption 
     Yes 
     No 
 
1.05 
1 
 
1.03 – 1.78 
 
0.05 
Fish Consumption 
     Yes 
     No 
 
1.09 
1 
 
1.06 – 1.90 
 
0.05 
Family history of  
ulcer 
     Yes 
     No 
 
4.45 
1 
 
1.95 – 10.15 
 
0.04 
Anti-parasitic drug 
use 
     Yes 
     No 
 
0.43 
1 
 
0.21 - 0.89 
 
 
0.02 
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We followed a cohort of 100 participants who were H. pylori positive for two years. Eighty 
percent (80/100) of these individuals were suffering from peptic ulcer and 20 % (20/100) were 
from the control group. The median age was 45 years (range: 28-63years). Forty five percent 
(45/100) were females while 55% (55/100) were males. All the participants of this cohort took 
medications for the treatment of H. pylori infection. However, only 75% (75/100) opted for a test 
to check their H. pylori status after finishing their treatment. Interestingly, treatment against H. 
pylori status was changed from initial positive to negative in only 53% of these (40/75) 
individuals. H. pylori infection was eradicated in 50% (35/70) of individuals who opted for the 
antibiotic therapy. (Figure 4) However, 40% (40/100) of individuals reported alleviation of initial 
gastric ailments within 6 months of completing the treatment. [Median time: 2 month (range: 1 
month – 6 month)]. Seventy percent (70/100) of individuals took the anti H. pylori triple therapy 
(H. pylori treatment kit) while 20% (20/100) of participants opted for traditional herbal treatment 
and only 10 % (10/100) choose other remedies. Interestingly, only 10% (10/100) individuals that 
were diagnosed of H. pylori sought a specialist (gastro-enterologist) consultation. (Table 16) 
Table 16: Prospective cohort participant characteristics in Pune, India (N=100) 
Characteristics N (%) 
Disease status 
Peptic ulcer 
Controls 
 
80 (80) 
20 (20)    
Median age (Range)  45 years (range: 28-63) 
Gender 
     Female 
     Male 
 
45 (45) 
55 (55) 
H. pylori treatment taken 
    Yes      
     No      
 
100 (100) 
0     (0) 
H. pylori diagnostic test taken after 
treatment 
    Yes      
     No      
 
 
75 (75) 
25 (25) 
H. pylori status changed from positive 
to negative after treatment 
    Yes      
     No    
 
 
40 (53) 
35 (47) 
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Characteristics N (%) 
Gastric complaints are alleviated after 
treatment 
    Yes      
     No    
 
 
40 (40) 
60 (60) 
Type of treatment taken 
Antibiotics (H. pylori treatment kit) 
Herbal 
Other 
 
70 (70) 
20 (20) 
10 (10) 
Sought gastro-enterologists’ 
consultation 
     Yes      
     No    
 
 
10 (10) 
90 (90) 
 
Anti H. pylori treatment 
taken
Antibiotics (n=70)
Herbal (n=20)
Other (n=10)
H. pylori diagnostic 
test taken after 
treatment
N =75
Antibiotics (n =70)
Herbal  (n=5)
H. pylori eradicated 
after treatment
N = 40
H. pylori eradicated 
after antibiotics 
treatment
N = 35
H. pylori eradicated 
after herbal treatment
N = 5
 
Figure 4 Anti H. pylori treatment success in Pune, India 
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Discussion 
This is the first study to document the prevalence of H. pylori among patients with peptic ulcer, 
stomach cancer and healthy individuals in Pune, Maharashtra. To our knowledge this is also the 
largest study (n=350) investigating risk factors of H. pylori prevalence in the state of 
Maharashtra, India. 
H. pylori infection is one of the most common infections worldwide. Epidemiological studies 
from India have shown 70%,[230] 77.2%,[223] 78% [231] and 79% [24] prevalence of H. pylori 
infection. In the present study, the prevalence of H. pylori infection was 61% in symptomatic and 
45 % in asymptomatic individuals. The prevalence of H. pylori infection was independent of 
gender in the present study, which is consistent with previous reports. [24]  Similarly, we found 
no association between age and prevalence of H. pylori infection. However, in most of the studies 
from developing countries it’s noted that within first 10 years of life the prevalence of H. pylori 
increases with age. [77, 232-238]  It is important to note that we enrolled only adults in our study 
in India. Hence we were unable to note the association between age and prevalence of H. pylori 
in our study. In some studies, lower education has shown to be associated with high prevalence of 
H. pylori.[130, 239, 240] In our study education was not associated with prevalence of H. pylori. 
This association should be explored in a larger and more diverse cohort of individuals,   perhaps 
recruiting individuals from villages near to Pune city as none of the participants in our study were 
uneducated. We recruited participants from the city of Pune and the educational attainment in our 
study cohort represents the education level of general population of Pune city.  
There is no doubt that improvements in the standards of living are an important factor in changing 
the risk factors related to H. pylori infection. A recent study has shown a sharp decrease of 
prevalence of H. pylori infection in St. Petersburg, Russia, comparing the prevalence in children 
in 1995 and 2005. [14] Another example that improvements in the standards of living are related 
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to H. pylori infection was reported by Parente et al.,[241] who compared the prevalence in 
children of low and high socioeconomic situation living in the same neighborhood in Terezina, 
Brazil. While in children 5–6 years old from low socioeconomic class, the prevalence reached 
70%, in the high socioeconomic class it was 17.4% .[241]  H. pylori infection is related to social 
class, being higher in low social class. The leading hypothesis for H. pylori transmission is person 
to person via contact with either gastric or fecal contents. The increasing prevalence of H. pylori 
infection with age in most of the places probably reflects the infection acquired at different ages 
as a result of poor sanitation facilities and hygienic practices as well as crowding during 
childhood. Water supply seems to be an important source of H. pylori infection. Klein et al. have 
shown in Lima, Peru that children whose homes had an external water source were three times 
more likely to be infected than children living in homes provided with internal water source. [79] 
Nurgalieva et al. reported that drinking river water had highest risk for H. pylori infection 
compared to tap water, suggesting that transmission of H. pylori infection can be water borne. 
[242] 
The importance of drinking river water as a transmission route of H. pylori was emphasized by 
Fujimura et al. in Japan, who collected samples from four rivers (upper middle and downstream). 
H. pylori was detected by nested polymerase chain reaction in the water of middle and 
downstream, suggesting that river water in the natural environment could be a risk factor for H. 
pylori transmission.[106] Using a bivariate analysis, Rodrigues et al. showed in children from an 
urban community in northeast Brazil a positive correlation between type of drinking water and H. 
pylori infection.[146] Boiling the water seems to be an effective way to prevent the infection, as 
suggested by Sung .[243] Our results confirm that source of drinking water is a risk factor for H. 
pylori infection. Prevalence was higher when the source of drinking water was a river and lower 
when the water was filtered or boiled [OR 1.05 (95% CI = 1.01–1.23)]. 
We also found that, the increasing frequency of eating outside was significantly associated with 
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prevalence of H. pylori in our study population. (Table 11) In developing countries, it is well 
known that eating restaurant food favors a feco-oral route transmission. SES has been considered 
as an important risk factor for H. pylori infection, probably because SES relates to hygienic 
practices. The prevalence of H. pylori infection has been shown to be influenced by SES in 
previous studies; [24, 244, 245]  similarly, it was dependent on SES in the present study.[31] Car 
ownership is a significant indicator of SES in state of Maharashtra and in Pune city. Specifically, 
in our study, individuals who owned a car were less likely to have H. pylori infection compared 
with participants who did not own a car (OR: 1.10 95% CI: 1.02-1.39). 
Meat has shown to be a risk factor for H. pylori infection in numerous studies. [117, 246-248] 
Consumption of meat was a significant risk factor for H. pylori infection in our study as well. 
[OR 2.35 (95% CI = 1.30–4.23)].On the other hand, consumption of chili peppers was shown to 
have a protective effect against H. pylori infection. In Maharashtra and in Pune chili peppers are 
common ingredients of most of the recipe. The chili peppers are added with turmeric (Curcuma 
longa) and cooking oil while preparing food items from produce. Previous studies have shown the 
protective effect of turmeric, chili peppers and some spices against H. pylori infection. [70] 
Several in vitro studies have looked at the effect of plant extracts on H. pylori. Anti-microbial 
effects have been reported for garlic [67], green tea [249], honey [250], thyme [251], some 
Iranian plants [252] and the essential oils from several species of mint [252]. Some of these 
studies have been validated in animals and confirmed the potential benefit of using plants as the 
source of anti-microbial agents against H. pylori. [70] However, the exact mechanism behind the 
bactericidal action of chili peppers has not been validated. Certainly, more work needs to be done 
in determining the active ingredients of chili peppers as well as performing studies on a larger 
number of patients. 
In our study 27 % participants were infected with helminth and 54% with protozoa and 47 % had 
some kind of parasite infection. Parasite infection was the only protective factor that remained 
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statically significant in the multivariate model. Parasite infestation is seen as another protective 
factor against diseases caused by H. pylori infection. In our study individuals who suffered from 
parasite infestations were less likely to have H. pylori infection. Moreover, individuals who had 
history of an anti parasite drug were less likely to have a peptic ulcer or a chronic gastric ailment. 
Indeed its hypothesized that concurrent enteric helminth infection can attenuate gastric atrophy 
via immune modulation. [71, 169]   
It is well known that the immune response to infectious agents leads to the expansion of particular 
CD4+ve T‐helper (Th) cell subsets. Th1 cells are reported to produce Interleukin (IL)–2, IL‐12 
and interferon γ (IFNγ), and are associated with cell‐mediated immunity, while Th2 cells have 
been reported to secrete Il‐4, IL‐5, IL‐6, IL‐10 and IL‐13, and are responsible for strong antibody 
responses, including IgE‐dependent allergies of the immediate type.[253] In general, Th1 
responses are associated with intracellular micro‐organisms including bacteria, protozoa and 
fungi, whereas extracellular pathogens induce Th2 responses. Studies to date have shown that 
natural infection with H. pylori, which is by and large an extracellular infection, leads to a 
Th1‐predominant response, with IL‐2, IL‐12, TNFα and IFNγ reported to be present in the gastric 
mucosa of H. pylori‐positive subjects. [254-256] In contrast, the Th2 cytokines IL‐4 and IL‐5 
have been found to be virtually absent in H. pylori infected subjects although a number of studies 
have reported IL‐10 to be present in the gastric mucosa of subjects with H. pylori‐related active 
gastritis.[256-259]  
Recently, Fox et al.[169] showed that mice infected with Helicobacter felis alone showed a Th1 
response, but in mice co‐infected with H. felis and the helminth H. polygyrus, there was a shift to 
a pattern of cytokine expression consistent with a Th2 immune response.[71] This corresponded 
to a significant reduction in mucosal hyperplasia, mucosal metaplasia and glandular atrophy. 
Thus, associated with the Th2 immune response, there was a marked reduction in 
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Helicobacter‐associated corpus atrophy, despite chronic inflammation and high Helicobacter 
colonization. If this is extrapolated to man, then intestinal helminth infection may provide a 
protective effect against development of gastric atrophy and gastric cancer. [71] Given that 
animal models do not necessarily replicate the human situation, Fox's study, indicates the 
complexity of biological actions associated with H. pylori which merits further investigation. 
In our study, H. pylori were seen as a significant risk factor for peptic ulcer disease. [OR: 1.70 
(95% CI: 1.03- 2.89)] as well as chronic gastric disease [OR: 2.48 (95% CI: 1.24- 4.96)]. The 
recognition of H. pylori infection as the main cause of ulcer [260] was undoubtedly the most 
important achievement in the past 50 years in gastroenterology. Showing that ulcer was a curable 
disease with a short treatment schedule represented a blessing to millions of people. [261-264] 
Lately, it was recognized that not only ulcer was related to H. pylori infection, but also the 
majority of gastric cancer [1, 265-267] and gastric mucosa-associated lymphoid tissue (MALT) 
lymphoma [268, 269]. Indeed eradication of H. pylori would probably be a very important tool in 
the management of upper digestive disease, particularly looking on high-risk cancer population.   
In our study, consumption of meat is suggested to be an important risk factor peptic ulcer. [OR: 
1.10 (95% CI: 1.02- 1.75)] and chronic gastric disease [OR: 1.05 (95% CI: 1.03- 1.78)]. 
Consumption of fish has also shown to be an important risk factor peptic ulcer. [OR: 1.05 (95% 
CI: 1.02- 1.89)] and chronic gastric disease [OR: 1.09 (95% CI: 1.06- 1.90)]. It is well known that 
individuals consume smoked, dried salted meat and fish mostly outside homes (in restaurants) in 
Pune. These put them at increased risk of acquiring H. pylori infection which may contribute to 
development of gastric pathologies such as peptic ulcer and or stomach cancer. Our findings are 
line with many other researchers who showed that consumption of smoked meat, salted fish and 
meat are risk factors for various gastric ailments including stomach cancer. Smoke-drying and 
preservation leads to formation of N-nitroso compounds. Nitrite reacts with amines and amides 
found in meats and other proteins to form N-nitroso compounds, which are animal carcinogens 
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and possible human carcinogens.[270] Furthermore, although salt is not an independent 
carcinogen, it is thought to increase the risk of gastric cancer through direct damage to the gastric 
mucosa, which results in gastritis, increased DNA synthesis, and cell proliferation.[271] This 
indirectly contributes to the development of chronic atrophic gastritis, leading to the development 
of stomach cancer. [121, 123, 272-276] Because of the presence of both salt and nitrite in 
processed fish and meats, its role in the development of stomach cancer cannot be ignored, as was 
found in the present study. Studies in the past have also shown positive associations of high 
intake of processed meats as a group or for individual cured meats. [277-282] 
Family history of ulcer has also shown to be a statistically significant risk factor for peptic ulcer 
[OR: 1.20 (95% CI: 1.08- 1.60)] and chronic gastric disease [OR: 4.45 (95% CI: 1.95- 10.15)] in 
our study. Positive family history of peptic ulcer has been well recognized as significant risk 
factor for peptic ulcer. [283-285] 
Alcohol and tobacco consumption did not emerge as a risk factor for peptic ulcer and chronic 
gastric disease in our study. However, consumption of snacks with alcohol was a statistically 
significant protective factor against peptic ulcer [OR: 0.32 (95% CI: 0.13- 0.78)]. This can be 
partially be explained by the link of type, amount of alcohol consumed by individuals from 
various socio economic strata. Usually individuals from higher SES strata consume snacks with 
alcohol; these individuals may be drinking in moderation and may be opting for treatment for 
their ailments compared to individuals from lower SES who don’t snack with their alcohol. These 
factors may be interlinked and may play a role in protection of gastric mucosal layer in people 
who drink but consume snacks while drinking. However, this hypothesis needs to be formally 
investigated. 
In our study we also followed a cohort of H. pylori positive individuals for approximately 2 years.  
All the 100 individuals opted for some kind of treatment to treat their H. pylori infection. 
71 
 
However, only 75% (75/100) opted for a test to check their H. pylori status after finishing their 
treatment. Interestingly, treatment against H. pylori status was changed from initial positive to 
negative in only 53% of these (40/75) individuals. This may reflect the poor success of H. pylori 
eradication by the triple therapy or by the herbal medicines that were used to treat H. pylori. The 
antimicrobial resistance of H. pylori is on the rise across the globe and is well documented in 
India. [28, 286-299] It is frequently observed that patients buy only a part of the H. pylori 
treatment kit or use only the half and once their symptoms are alleviated they share the rest of the 
kit with their friends and family members (personal observation). These facts certainly merit 
attention and patient education should be made a mandatory part while prescribing anti microbial 
agents.  
Our study has some limitations. First we were not successful in enrolling the desired number of 
patients (n=50) diagnosed with stomach cancer. We believe this is owing to the facts related to 
high mortality rate among individuals diagnosed with stomach cancer in India and also to low 
proportion of patients diagnosed with stomach cancer seeking active treatments. Future studies 
need to utilize innovative strategies such as individual patient counseling and organizing patient 
education seminars to boost enrollment of patients diagnosed with stomach cancer into research 
studies. We came across a lot of missing data for the amount of cigarettes and alcohol consumed 
by the participants. We believe owing to the stigma attached to smoking and alcohol consumption 
individuals participating in this study were reluctant to share the amount of alcohol and tobacco 
consumed by them. Hence, we were unable to investigate the dose response of tobacco and 
alcohol consumption.  We also made an attempt to elucidate the intra-familial transmission 
pathways of H. pylroi by enquiring about spouses’ H. pylori status. Unfortunately 74% of our 
participant did not know H. pylori status of their spouse. Almost all of them reported that their 
spouse was never tested for presence of H. pylori. Lastly, owing to the financial restraints and 
non availability of technical expertise required for isolation of DNA from stool samples and 
72 
 
genotyping were unable to conduct the genotyping of H. pylori to detect the prevalence of CagA 
positive and furthermore East Asian CagA H. pylori infection in Pune. This area certainly needs 
attention as previous studies from India have shown high prevalence of CagA positive H. pylori 
among symptomatic population.  
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Chapter Five 
Conclusions 
Our studies in Ecuador and Panama documented the prevalence of virulent East Asian CagA 
positive H. pylori among healthy individuals. This finding is of utmost importance in 
understanding the patho-physiology of stomach cancer in Ecuador and Panama. It is well 
documented that the grades of inflammation, activity of gastritis, and atrophy are significantly 
higher in gastritis patients infected with the East Asian CagA-positive strain than in gastritis 
patients infected with the CagA-negative or Western CagA-positive strains. [300-303] The 
prevalence of the East Asian CagA-positive strain is associated with the mortality rate of gastric 
cancer in Asia. Endemic circulation of H. pylori populations carrying biologically more active 
CagA proteins in East Asian countries, where the mortality rate of gastric cancer is among the 
highest in the world, may be involved in increasing the risk of gastric cancer in populations such 
as of Ecuador and Panama. [304-306] This can explain the difference between the incidence rate 
of stomach cancer in Ecuador and Panama.  Our study from Pune, India underscores H. pylori 
along with family history of peptic ulcer, meat and fish consumption as significant risk factors for 
peptic ulcer and chronic gastric disease. Our study in India also confirms low SES along with 
meat consumption and tobacco smoking as one of the risk factors for H. pylori infection. We also 
highlight the statistically significant association of increased frequency of eating restaurant food 
and drinking non filtered water as risk factors for H. pylori infection. These may suggest the feco-
oral and water-born transmission of H. pylroi in Pune, India. Interestingly we also bring to light 
the role of chili peppers consumption as protective factor against H. pylori infection. Last but not 
the least we emphasize the protective influence of concurrent parasite infestation on H. pylori 
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infection and development of chronic gastric ailments. This underscores the need of research to 
investigate the relationship of various dietary factors especially chili peppers and other protective 
factors such as parasite infestation and H. pylori infection in developing countries. 
In summary, the speculations in this paper are based on objective scientific evidence that fits with 
the changing patterns of peptic ulcer and gastric cancer that we have seen. We recommend studies 
in countries like India and Ecuador to investigate the epidemiology of specific types of parasite 
infections as well as the influence of diet, host genetic susceptibility, H. pylori genotype and other 
co-morbidity states in determining gastric cancer rates. Moreover, the protective effect of 
concurrent parasite infection on the development of pre-neoplastic lesions such as gastric atrophy 
should be extended to studies on gastric cancer. We have highlighted the protective role of chili 
peppers against H. pylori infection. Although the bactericidal and anti-adhesive effects of chili 
peppers, ginger, cumin, and turmeric, have been shown in vitro, further studies are needed to be 
carried out to investigate their effects in vivo, to see whether the extracts are able to remain 
effective despite the harsh process of digestion. Lastly, the issues of treatment compliance leading 
to anti microbial resistance are also equally vital and need to be studied in larger population based 
studies.  
 
 
  
75 
 
 
 
 
References 
1. IARC Monographs of the Evaluation of Carcinogenic Risks to Humans. Available 
from: http://www.iarc.fr/IARCPress/mono/index.php. 
2. Poddar, U. and S.K. Yachha, Helicobacter pylori in children: an Indian 
perspective. Indian Pediatr, 2007. 44(10): p. 761-70. 
3. Ernst, P.B. and B.D. Gold, Helicobacter pylori in childhood: new insights into the 
immunopathogenesis of gastric disease and implications for managing infection 
in children. J Pediatr Gastroenterol Nutr, 1999. 28(5): p. 462-73. 
4. Fiedorek, S.C., et al., Factors influencing the epidemiology of Helicobacter pylori 
infection in children. Pediatrics, 1991. 88(3): p. 578-82. 
5. Mitchell, H.M., The epidemiology of Helicobacter pylori. Curr Top Microbiol 
Immunol, 1999. 241: p. 11-30. 
6. Lehours, P. and O. Yilmaz, Epidemiology of Helicobacter pylori infection. 
Helicobacter, 2007. 12 Suppl 1: p. 1-3. 
7. Leverstein-van Hall, M.A., et al., Transmission of Helicobacter pylori via faeces. 
Lancet, 1993. 342(8884): p. 1419-20. 
8. Stone, M.A., Transmission of Helicobacter pylori. Postgrad Med J, 1999. 
75(882): p. 198-200. 
9. Axon, A.T., The transmission of Helicobacter pylori: which theory fits the facts? 
Eur J Gastroenterol Hepatol, 1996. 8(1): p. 1-2. 
10. Goodman, K.J. and P. Correa, The transmission of Helicobacter pylori. A critical 
review of the evidence. Int J Epidemiol, 1995. 24(5): p. 875-87. 
11. Abraham, P. and S.G. Kulkarni, Transmission routes of Helicobacter pylori. 
Indian J Gastroenterol, 2000. 19 Suppl 1: p. S7-9; discussion S9-10. 
12. Mendall, M.A., Transmission of Helicobacter pylori. Semin Gastrointest Dis, 
1997. 8(3): p. 113-23. 
13. Megraud, F., Epidemiology of Helicobacter pylori infection. Gastroenterol Clin 
North Am, 1993. 22(1): p. 73-88. 
14. Malaty, H.M., Epidemiology of Helicobacter pylori infection. Best Pract Res Clin 
Gastroenterol, 2007. 21(2): p. 205-14. 
15. Malaty, H.M., et al., Prevalence of Helicobacter pylori infection in Korean 
children: inverse relation to socioeconomic status despite a uniformly high 
prevalence in adults. Am J Epidemiol, 1996. 143(3): p. 257-62. 
16. Malaty, H.M., et al., Helicobacter pylori and socioeconomic factors in Russia. 
Helicobacter, 1996. 1(2): p. 82-7. 
17. Mitchell, H.M., et al., Epidemiology of Helicobacter pylori in southern China: 
identification of early childhood as the critical period for acquisition. J Infect Dis, 
1992. 166(1): p. 149-53. 
18. Yamaoka, Y., et al., Conservation of Helicobacter pylori genotypes in different 
ethnic groups in Houston, Texas. J Infect Dis, 2000. 181(6): p. 2083-6. 
76 
 
19. Matysiak-Budnik, T., et al., Helicobacter pylori infection in Eastern Europe: 
seroprevalence in the Polish population of Lower Silesia. Am J Gastroenterol, 
1996. 91(12): p. 2513-5. 
20. Ashorn, M., et al., Helicobacter pylori infection in Finnish children and 
adolescents. A serologic cross-sectional and follow-up study. Scand J 
Gastroenterol, 1995. 30(9): p. 876-9. 
21. Kumagai, T., et al., Acquisition versus loss of Helicobacter pylori infection in 
Japan: results from an 8-year birth cohort study. J Infect Dis, 1998. 178(3): p. 
717-21. 
22. Nurgalieva, Z.Z., et al., Helicobacter pylori infection in Kazakhstan: effect of 
water source and household hygiene. Am J Trop Med Hyg, 2002. 67(2): p. 201-6. 
23. Dore, M.P., et al., Risk Factors Associated with Helicobacter pylori Infection 
among Children in a Defined Geographic Area. Clin Infect Dis, 2002. 35(3): p. 
240-5. 
24. Graham, D.Y., et al., Seroepidemiology of Helicobacter pylori infection in India. 
Comparison of developing and developed countries. Dig Dis Sci, 1991. 36(8): p. 
1084-8. 
25. Ahmad, M.M., et al., Prevalence of Helicobacter pylori in asymptomatic 
population--a pilot serological study in Bangladesh. J Epidemiol, 1997. 7(4): p. 
251-4. 
26. Perez-Perez, G.I., et al., Seroprevalence of helicobacter pylori infection in 
couples. J Clin Microbiol, 1991. 29(3): p. 642-4. 
27. Mazumder, D.N. and U.C. Ghoshal, Epidemiology of Helicobacter pylori in 
India. Indian J Gastroenterol, 1997. 16 Suppl 1: p. S3-5. 
28. Gill, H.H., et al., Epidemiology of Helicobacter pylori: the Indian scenario. 
Indian J Gastroenterol, 1993. 12(1): p. 9-11. 
29. Abasiyanik, M.F., M. Tunc, and B.A. Salih, Enzyme immunoassay and 
immunoblotting analysis of Helicobacter pylori infection in Turkish asymptomatic 
subjects. Diagn Microbiol Infect Dis, 2004. 50(3): p. 173-7. 
30. Reshetnikov, O.V., et al., Helicobacter pylori seropositivity among adolescents in 
Novosibirsk, Russia: prevalence and associated factors. J Pediatr Gastroenterol 
Nutr, 2003. 36(1): p. 72-6. 
31. Singh, V., et al., Epidemiology of Helicobacter pylori and peptic ulcer in India. J 
Gastroenterol Hepatol, 2002. 17(6): p. 659-65. 
32. Miwa, H., M.F. Go, and N. Sato, H. pylori and gastric cancer: the Asian enigma. 
Am J Gastroenterol, 2002. 97(5): p. 1106-12. 
33. Tsubono Y, T.T., Iwase Y, Iitoi Y, Akabane M, Tsugane S. , Nutrient 
consumption and gastric cancer mortality in five regions of Japan. . Nutr Cancer, 
1997. 27: p. 310-315. 
34. Wong, B.C., et al., Differential Helicobacter pylori infection rates in two 
contrasting gastric cancer risk regions of South China. China Gastric Cancer 
Study Group. J Gastroenterol Hepatol, 1999. 14(2): p. 120-5. 
35. Abraham, P. and S.J. Bhatia, Position paper on Helicobacter pylori in India. 
Indian Society of Gastroenterology. Indian J Gastroenterol, 1997. 16 Suppl 1: p. 
S29-33. 
36. Batmanabane, V., V. Kate, and N. Ananthakrishnan, Prevalence of Helicobacter 
77 
 
pylori in patients with portal hypertensive gastropathy--a study from south India. 
Med Sci Monit, 2004. 10(4): p. CR133-6. 
37. Bhasin, D.K., et al., Helicobacter pylori in gastric cancer in India. Trop 
Gastroenterol, 1999. 20(2): p. 70-2. 
38. Choudhuri, G. and S. Mohindra, Epidemiology of Helicobacter pylori in India. 
Indian J Gastroenterol, 2000. 19 Suppl 1: p. S3-5; discussion S5-6. 
39. Mohandas, K.M., Helicobacter pylori and gastric lymphoma. N Engl J Med, 
1994. 331(11): p. 746. 
40. Tovey, F.I., Helicobacter pylori infection. Trop Doct, 1995. 25(2): p. 49. 
41. Khuroo MS, Z.S., Mahajan R, Banday MA. , High incidence of oesophageal and 
gastric cancer in Kashmir in a population with special personal and dietary 
habits. Gut, 1992. 33: p. 11-15. 
42. Tovey, F.I., et al., Helicobacter pylori and peptic ulcer recurrence. Gut, 1992. 
33(9): p. 1293. 
43. Kate, V. and N. Ananthakrishnan, Helicobacter pylori and gastric carcinoma: 
evidence for the link. Natl Med J India, 2000. 13(6): p. 329. 
44. Kate, V., et al., Prevalence of Helicobacter pylori infection in disorders of the 
upper gastrointestinal tract in south India. Natl Med J India, 1998. 11(1): p. 5-8. 
45. Khanna, A.K., et al., Correlation of Helicobacter pylori and gastric carcinoma. J 
Postgrad Med, 2002. 48(1): p. 27-8. 
46. Karnes, W.E., Jr., et al., Elevation of meal-stimulated gastrin release in subjects 
with Helicobacter pylori infection: reversal by low intragastric pH. Rev Infect 
Dis, 1991. 13 Suppl 8: p. S665-70. 
47. Asaka, M., et al., Relationship between Helicobacter pylori infection, atrophic 
gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol 
Hepatol, 1995. 7 Suppl 1: p. S7-10. 
48. Singh, K. and U.C. Ghoshal, Causal role of Helicobacter pylori infection in 
gastric cancer: an Asian enigma. World J Gastroenterol, 2006. 12(9): p. 1346-51. 
49. Graham, D.Y., Helicobacter pylori infection in the pathogenesis of duodenal 
ulcer and gastric cancer: a model. Gastroenterology, 1997. 113(6): p. 1983-91. 
50. Hansson, L.E., et al., The risk of stomach cancer in patients with gastric or 
duodenal ulcer disease. N Engl J Med, 1996. 335(4): p. 242-9. 
51. Lu, H., Y. Yamaoka, and D.Y. Graham, Helicobacter pylori virulence factors: 
facts and fantasies. Curr Opin Gastroenterol, 2005. 21(6): p. 653-9. 
52. Mukhopadhyay, A.K., et al., Distinctiveness of genotypes of Helicobacter pylori 
in Calcutta, India. J Bacteriol, 2000. 182(11): p. 3219-27. 
53. Singh, M., et al., Genotypes of Helicobacter pylori in children with upper 
abdominal pain. J Gastroenterol Hepatol, 2003. 18(9): p. 1018-23. 
54. Kumar, S., et al., Antibodies to Cag A protein are not predictive of serious 
gastroduodenal disease in Indian patients. Indian J Gastroenterol, 1998. 17(4): p. 
126-8. 
55. Ghoshal, U.C., et al., Frequency of Helicobacter pylori and CagA antibody in 
patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci, 
2008. 53(5): p. 1215-22. 
56. Li, L., et al., Helicobacter pylori strain and the pattern of gastritis among first-
degree relatives of patients with gastric carcinoma. Helicobacter, 2002. 7(6): p. 
78 
 
349-55. 
57. Nomura, A.M., et al., Helicobacter pylori CagA seropositivity and gastric 
carcinoma risk in a Japanese American population. J Infect Dis, 2002. 186(8): p. 
1138-44. 
58. Yang, G.F., et al., Expression of nuclear factor-kappa B and target genes in 
gastric precancerous lesions and adenocarcinoma: association with Helicobactor 
pylori cagA (+) infection. World J Gastroenterol, 2004. 10(4): p. 491-6. 
59. Bravo, L.E., et al., Virulence-associated genotypes of Helicobacter pylori: do they 
explain the African enigma? Am J Gastroenterol, 2002. 97(11): p. 2839-42. 
60. El-Omar, E.M., et al., Increased prevalence of precancerous changes in relatives 
of gastric cancer patients: critical role of H. pylori. Gastroenterology, 2000. 
118(1): p. 22-30. 
61. Uemura, N., et al., Helicobacter pylori infection and the development of gastric 
cancer. N Engl J Med, 2001. 345(11): p. 784-9. 
62. Gonzalez, C.A., J.M. Sanz, and A. Agudo, [Risk factors for gastric cancer]. 
Gastroenterol Hepatol, 1997. 20(5): p. 239-47. 
63. Malaty, H.M., et al., Are genetic influences on peptic ulcer dependent or 
independent of genetic influences for Helicobacter pylori infection? Arch Intern 
Med, 2000. 160(1): p. 105-9. 
64. Gajalakshmi CK, S.V., Lifestyle and risk of stomach cancer: a hospital-based 
case-control study. . Int J Epidemiol 1996. 25: p. 1146-1153. 
65. Rao DN, G.B., Dinshaw KA, Mohandas KM., A casecontrol study of stomach 
cancer in Mumbai, India. Int J Cancer 2002. 99: p. 727-731. 
66. Lunet, N. and H. Barros, Helicobacter pylori infection and gastric cancer: facing 
the enigmas. Int J Cancer, 2003. 106(6): p. 953-60. 
67. Jonkers, D., et al., Antibacterial effect of garlic and omeprazole on Helicobacter 
pylori. J Antimicrob Chemother, 1999. 43(6): p. 837-9. 
68. Foryst-Ludwig, A., et al., Curcumin blocks NF-kappaB and the motogenic 
response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res 
Commun, 2004. 316(4): p. 1065-72. 
69. Mahady, G.B., et al., Turmeric (Curcuma longa) and curcumin inhibit the growth 
of Helicobacter pylori, a group 1 carcinogen. Anticancer Res, 2002. 22(6C): p. 
4179-81. 
70. O'Mahony, R., et al., Bactericidal and anti-adhesive properties of culinary and 
medicinal plants against Helicobacter pylori. World J Gastroenterol, 2005. 
11(47): p. 7499-507. 
71. Fox, J.G., et al., Concurrent enteric helminth infection modulates inflammation 
and gastric immune responses and reduces helicobacter-induced gastric atrophy. 
Nat Med, 2000. 6(5): p. 536-42. 
72. Whary, M.T., et al., Intestinal helminthiasis in Colombian children promotes a 
Th2 response to Helicobacter pylori: possible implications for gastric 
carcinogenesis. Cancer Epidemiol Biomarkers Prev, 2005. 14(6): p. 1464-9. 
73. Torres, J., et al., A comprehensive review of the natural history of Helicobacter 
pylori infection in children. Arch Med Res, 2000. 31(5): p. 431-69. 
74. Brown, L.M., Helicobacter pylori: epidemiology and routes of transmission. 
Epidemiol Rev, 2000. 22(2): p. 283-97. 
79 
 
75. Imrie, C., et al., Is Helicobacter pylori infection in childhood a risk factor for 
gastric cancer? Pediatrics, 2001. 107(2): p. 373-80. 
76. O'Rourke, K., et al., Determinants of geographic variation in Helicobacter pylori 
infection among children on the US-Mexico border. Am J Epidemiol, 2003. 
158(8): p. 816-24. 
77. Rowland, M., et al., Age-specific incidence of Helicobacter pylori. 
Gastroenterology, 2006. 130(1): p. 65-72; quiz 211. 
78. Muhsen, K., et al., Prevalence and risk factors of Helicobacter pylori infection 
among healthy 3- to 5-year-old Israeli Arab children. Epidemiol Infect, 2006. 
134(5): p. 990-6. 
79. Klein, P.D., et al., Water source as risk factor for Helicobacter pylori infection in 
Peruvian children. Gastrointestinal Physiology Working Group. Lancet, 1991. 
337(8756): p. 1503-6. 
80. Goodman, K.J., et al., Nutritional factors and Helicobacter pylori infection in 
Colombian children. J Pediatr Gastroenterol Nutr, 1997. 25(5): p. 507-15. 
81. Moreira, E.D., Jr., et al., Risk factors for Helicobacter pylori infection in children: 
is education a main determinant? Epidemiol Infect, 2004. 132(2): p. 327-35. 
82. Ueda, M., et al., Helicobacter pylori risk associated with childhood home 
environment. Cancer Sci, 2003. 94(10): p. 914-8. 
83. de Martel, C. and J. Parsonnet, Helicobacter pylori infection and gender: a meta-
analysis of population-based prevalence surveys. Dig Dis Sci, 2006. 51(12): p. 
2292-301. 
84. Cullen, D.J., et al., When is Helicobacter pylori infection acquired? Gut, 1993. 
34(12): p. 1681-2. 
85. Mendall, M.A., et al., Childhood living conditions and Helicobacter pylori 
seropositivity in adult life. Lancet, 1992. 339(8798): p. 896-7. 
86. McCallion, W.A., et al., Helicobacter pylori infection in children: relation with 
current household living conditions. Gut, 1996. 39(1): p. 18-21. 
87. Parsonnet, J., et al., Symptoms and risk factors of Helicobacter pylori infection in 
a cohort of epidemiologists. Gastroenterology, 1992. 102(1): p. 41-6. 
88. Rothenbacher, D., et al., Prevalence and determinants of Helicobacter pylori 
infection in preschool children: a population-based study from Germany. Int J 
Epidemiol, 1998. 27(1): p. 135-41. 
89. Herbarth, O., et al., Helicobacter pylori prevalences and risk factors among 
school beginners in a German urban center and its rural county. Environ Health 
Perspect, 2001. 109(6): p. 573-7. 
90. Webb, P.M., et al., Relation between infection with Helicobacter pylori and living 
conditions in childhood: evidence for person to person transmission in early life. 
Bmj, 1994. 308(6931): p. 750-3. 
91. Luzza, F., et al., Suggestion against an oral-oral route of transmission for 
Helicobacter pylori infection: a seroepidemiological study in a rural area. Dig 
Dis Sci, 1998. 43(7): p. 1488-92. 
92. Bode, G., et al., Pets are not a risk factor for Helicobacter pylori infection in 
young children: results of a population-based study in Southern Germany. Pediatr 
Infect Dis J, 1998. 17(10): p. 909-12. 
93. Bazzoli, F., Key points from the revised Maastricht Consensus Report: the impact 
80 
 
on general practice. Eur J Gastroenterol Hepatol, 2001. 13 Suppl 2: p. S3-7. 
94. Brown, L.M., et al., Helicobacter pylori infection in rural China: exposure to 
domestic animals during childhood and adulthood. Scand J Infect Dis, 2001. 
33(9): p. 686-91. 
95. Goodman, K.J., et al., Helicobacter pylori infection in the Colombian Andes: a 
population-based study of transmission pathways. Am J Epidemiol, 1996. 144(3): 
p. 290-9. 
96. Dore, M.P., et al., High prevalence of Helicobacter pylori infection in shepherds. 
Dig Dis Sci, 1999. 44(6): p. 1161-4. 
97. Liu, W.Z., et al., Seroprevalence of Helicobacter pylori infection in medical staff 
in Shanghai. Scand J Gastroenterol, 1996. 31(8): p. 749-52. 
98. Lin, S.K., et al., Helicobacter pylori prevalence in endoscopy and medical staff. J 
Gastroenterol Hepatol, 1994. 9(4): p. 319-24. 
99. Su, Y.C., et al., High seroprevalence of IgG against Helicobacter pylori among 
endoscopists in Taiwan. Dig Dis Sci, 1996. 41(8): p. 1571-6. 
100. Braden, B., et al., Endoscopy is not a risk factor for Helicobacter pylori infection-
-but medical practice is. Gastrointest Endosc, 1997. 46(4): p. 305-10. 
101. Nishikawa, J., et al., Seroprevalence of immunoglobulin G antibodies against 
Helicobacter pylori among endoscopy personnel in Japan. Gastrointest Endosc, 
1998. 48(3): p. 237-43. 
102. Lin, S.K., et al., The prevalence of Helicobacter pylori in practising dental staff 
and dental students. Aust Dent J, 1998. 43(1): p. 35-9. 
103. Banatvala, N., et al., Helicobacter pylori infection in dentists--a case-control 
study. Scand J Infect Dis, 1995. 27(2): p. 149-51. 
104. Matsuda, R. and T. Morizane, Helicobacter pylori infection in dental 
professionals: a 6-year prospective study. Helicobacter, 2005. 10(4): p. 307-11. 
105. Mastromarino, P., et al., Does hospital work constitute a risk factor for 
Helicobacter pylori infection? J Hosp Infect, 2005. 60(3): p. 261-8. 
106. Fujimura, S., S. Kato, and T. Kawamura, Helicobacter pylori in Japanese river 
water and its prevalence in Japanese children. Lett Appl Microbiol, 2004. 38(6): 
p. 517-21. 
107. Rolle-Kampczyk, U.E., et al., Well water--one source of Helicobacter pylori 
colonization. Int J Hyg Environ Health, 2004. 207(4): p. 363-8. 
108. Yamashita, Y., et al., Epidemiology of Helicobacter pylori infection in children: a 
serologic study of the Kyushu region in Japan. Pediatr Int, 2001. 43(1): p. 4-7. 
109. Reshetnikov, O.V., et al., Seroprevalence of Helicobacter pylori infection in 
Siberia. Helicobacter, 2001. 6(4): p. 331-6. 
110. Fontham, E.T., et al., Determinants of Helicobacter pylori infection and chronic 
gastritis. Am J Gastroenterol, 1995. 90(7): p. 1094-101. 
111. Jones, N.L., S. Shabib, and P.M. Sherman, Capsaicin as an inhibitor of the 
growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol Lett, 1997. 
146(2): p. 223-7. 
112. Lopez-Carrillo, L., et al., Capsaicin consumption, Helicobacter pylori positivity 
and gastric cancer in Mexico. Int J Cancer, 2003. 106(2): p. 277-82. 
113. Guo, Z., et al., A case-control study on risk factors of helicobacter pylori infection 
in out-patients with stomach diseases. Zhonghua Yu Fang Yi Xue Za Zhi, 2002. 
81 
 
36(3): p. 187-90. 
114. Jarosz, M., et al., Effects of high dose vitamin C treatment on Helicobacter pylori 
infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev, 
1998. 7(6): p. 449-54. 
115. Malaty, H.M., et al., Co-twin study of the effect of environment and dietary 
elements on acquisition of Helicobacter pylori infection. Am J Epidemiol, 1998. 
148(8): p. 793-7. 
116. Olafsson, S. and A. Berstad, Changes in food tolerance and lifestyle after 
eradication of Helicobacter pylori. Scand J Gastroenterol, 2003. 38(3): p. 268-76. 
117. Phukan, R.K., et al., Dietary habits and stomach cancer in Mizoram, India. J 
Gastroenterol, 2006. 41(5): p. 418-24. 
118. Qasim, A. and C.A. O'Morain, Review article: treatment of Helicobacter pylori 
infection and factors influencing eradication. Aliment Pharmacol Ther, 2002. 16 
Suppl 1: p. 24-30. 
119. Webberley, M.J., et al., Seroepidemiology of Helicobacter pylori infection in 
vegans and meat-eaters. Epidemiol Infect, 1992. 108(3): p. 457-62. 
120. Bergin, I.L., B.J. Sheppard, and J.G. Fox, Helicobacter pylori infection and high 
dietary salt independently induce atrophic gastritis and intestinal metaplasia in 
commercially available outbred Mongolian gerbils. Dig Dis Sci, 2003. 48(3): p. 
475-85. 
121. Fox, J.G., et al., High-salt diet induces gastric epithelial hyperplasia and parietal 
cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer 
Res, 1999. 59(19): p. 4823-8. 
122. Gamboa-Dominguez, A., et al., Salt and stress synergize H. pylori-induced 
gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils. Dig 
Dis Sci, 2007. 52(6): p. 1517-26. 
123. Kato, S., et al., High salt diets dose-dependently promote gastric chemical 
carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with 
a shift in mucin production from glandular to surface mucous cells. Int J Cancer, 
2006. 119(7): p. 1558-66. 
124. Rothenbacher, D., et al., Use of commonly prescribed antibiotics is not associated 
with prevalence of Helicobacter pylori infection in adults. Scand J Gastroenterol, 
1997. 32(11): p. 1096-9. 
125. Tindberg, Y., et al., Helicobacter pylori infection in Swedish school children: lack 
of evidence of child-to-child transmission outside the family. Gastroenterology, 
2001. 121(2): p. 310-6. 
126. Leung, W.K., et al., Follow up of serial urea breath test results in patients after 
consumption of antibiotics for non-gastric infections. World J Gastroenterol, 
2002. 8(4): p. 703-6. 
127. Rothenbacher, D., et al., History of antibiotic treatment and prevalence of H. 
pylori infection among children: results of a population-based study. J Clin 
Epidemiol, 1998. 51(3): p. 267-71. 
128. Bures, J., et al., Epidemiology of Helicobacter pylori infection in the Czech 
Republic. Helicobacter, 2006. 11(1): p. 56-65. 
129. Replogle, M.L., et al., Biologic sex as a risk factor for Helicobacter pylori 
infection in healthy young adults. Am J Epidemiol, 1995. 142(8): p. 856-63. 
82 
 
130. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 
asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut, 
1993. 34(12): p. 1672-6. 
131. Malaty, H.M., et al., Helicobacter pylori in Hispanics: comparison with blacks 
and whites of similar age and socioeconomic class. Gastroenterology, 1992. 
103(3): p. 813-6. 
132. Malaty, H.M. and D.Y. Graham, Importance of childhood socioeconomic status 
on the current prevalence of Helicobacter pylori infection. Gut, 1994. 35(6): p. 
742-5. 
133. Murray, L.J., et al., Epidemiology of Helicobacter pylori infection among 4742 
randomly selected subjects from Northern Ireland. Int J Epidemiol, 1997. 26(4): 
p. 880-7. 
134. Peach, H.G., D.C. Pearce, and S.J. Farish, Helicobacter pylori infection in an 
Australian regional city: prevalence and risk factors. Med J Aust, 1997. 167(6): 
p. 310-3. 
135. Hopkins, R.J., et al., Seroprevalence of Helicobacter pylori in Chile: vegetables 
may serve as one route of transmission. J Infect Dis, 1993. 168(1): p. 222-6. 
136. Chow, T.K., et al., Helicobacter pylori in Melbourne Chinese immigrants: 
evidence for oral-oral transmission via chopsticks. J Gastroenterol Hepatol, 1995. 
10(5): p. 562-9. 
137. Buckley, M., et al., Management of dyspepsia in primary care. Antibiotic 
resistance is a problem. Bmj, 1998. 316(7141): p. 1388. 
138. Rothenbacher, D., et al., Active infection with Helicobacter pylori in an 
asymptomatic population of middle aged to elderly people. Epidemiol Infect, 
1998. 120(3): p. 297-303. 
139. Souto, F.J., et al., Prevalence of Helicobacter pylori infection in a rural area of 
the state of Mato Grosso, Brazil. Mem Inst Oswaldo Cruz, 1998. 93(2): p. 171-4. 
140. Torres, J., et al., A community-based seroepidemiologic study of Helicobacter 
pylori infection in Mexico. J Infect Dis, 1998. 178(4): p. 1089-94. 
141. Bani-Hani, K.E., et al., Prevalence and risk factors of Helicobacter pylori 
infection in healthy schoolchildren. Chin J Dig Dis, 2006. 7(1): p. 55-60. 
142. Teh, B.H., et al., Seroprevalence and associated risk factors of Helicobacter 
pylori infection in Taiwan. Anticancer Res, 1994. 14(3B): p. 1389-92. 
143. Koch, A., et al., Seroprevalence and risk factors for Helicobacter pylori infection 
in Greenlanders. Helicobacter, 2005. 10(5): p. 433-42. 
144. Breuer, T., et al., Prevalence of and risk factors for Helicobacter pylori infection 
in the western part of Germany. Eur J Gastroenterol Hepatol, 1996. 8(1): p. 47-52. 
145. Al-Shamahy, H.A., Seroprevalence of Helicobacter pylori among children in 
Sana'a, Yemen. Ann Saudi Med, 2005. 25(4): p. 299-303. 
146. Rodrigues, M.N., et al., Prevalence of Helicobacter pylori infection in children 
from an urban community in north-east Brazil and risk factors for infection. Eur J 
Gastroenterol Hepatol, 2004. 16(2): p. 201-5. 
147. Parsonnet, J., Bacterial infection as a cause of cancer. Environ Health Perspect, 
1995. 103 Suppl 8: p. 263-8. 
148. Tindberg, Y., M. Blennow, and M. Granstrom, Clinical symptoms and social 
factors in a cohort of children spontaneously clearing Helicobacter pylori 
83 
 
infection. Acta Paediatr, 1999. 88(6): p. 631-5. 
149. Wizla-Derambure, N., et al., Familial and community environmental risk factors 
for Helicobacter pylori infection in children and adolescents. J Pediatr 
Gastroenterol Nutr, 2001. 33(1): p. 58-63. 
150. Nessa, J., et al., Human serum antibody response to Helicobacter pylori whole 
cell antigen in an institutionalized Bangladeshi population. J Appl Microbiol, 
2001. 90(1): p. 68-72. 
151. Wallace, M.R., Risk factors for Helicobacter pylori resistance. Curr Gastroenterol 
Rep, 2002. 4(4): p. 277. 
152. Kikuchi, S., Epidemiology of Helicobacter pylori and gastric cancer. Gastric 
Cancer, 2002. 5(1): p. 6-15. 
153. Rothenbacher, D., et al., Helicobacter pylori in out-patients of a general 
practitioner: prevalence and determinants of current infection. Epidemiol Infect, 
1997. 119(2): p. 151-7. 
154. Kyriazanos, I., et al., A cohort study on Helicobacter pylori serology before and 
after induction in the Hellenic Navy. Mil Med, 2001. 166(5): p. 411-5. 
155. Grimm, W. and W. Fischbach, [Helicobacter pylori infection in children and 
juveniles: an epidemiological study on prevalence, socio-economic factors and 
symptoms]. Dtsch Med Wochenschr, 2003. 128(37): p. 1878-83. 
156. Ma, J.L., et al., Helicobacter pylori infection and mode of transmission in a 
population at high risk of stomach cancer. Int J Epidemiol, 1998. 27(4): p. 570-3. 
157. Brenner, H., et al., Parental history of gastric or duodenal ulcer and prevalence 
of Helicobacter pylori infection in preschool children: population based study. 
Bmj, 1998. 316(7132): p. 665. 
158. Goodman, K.J. and P. Correa, Transmission of Helicobacter pylori among 
siblings. Lancet, 2000. 355(9201): p. 358-62. 
159. Dominici, P., et al., Familial clustering of Helicobacter pylori infection: 
population based study. Bmj, 1999. 319(7209): p. 537-40. 
160. Rothenbacher, D., et al., Helicobacter pylori among preschool children and their 
parents: evidence of parent-child transmission. J Infect Dis, 1999. 179(2): p. 398-
402. 
161. Rothenbacher, D., G. Bode, and H. Brenner, Dynamics of Helicobacter pylori 
infection in early childhood in a high-risk group living in Germany: loss of 
infection higher than acquisition. Aliment Pharmacol Ther, 2002. 16(9): p. 1663-
8. 
162. Rocha, G.A., et al., Transmission of Helicobacter pylori infection in families of 
preschool-aged children from Minas Gerais, Brazil. Trop Med Int Health, 2003. 
8(11): p. 987-91. 
163. Kivi, M., et al., Helicobacter pylori status in family members as risk factors for 
infection in children. Epidemiol Infect, 2005. 133(4): p. 645-52. 
164. Aguemon, B.D., et al., Prevalence and risk-factors for Helicobacter pylori 
infection in urban and rural Beninese populations. Clin Microbiol Infect, 2005. 
11(8): p. 611-7. 
165. Glynn, M.K., et al., Seroincidence of Helicobacter pylori infection in a cohort of 
rural Bolivian children: acquisition and analysis of possible risk factors. Clin 
Infect Dis, 2002. 35(9): p. 1059-65. 
84 
 
166. Selimoglu, M.A., V. Ertekin, and T. Inandi, Seroepidemiology of Helicobacter 
pylori infection in children living in eastern Turkey. Pediatr Int, 2002. 44(6): p. 
666-9. 
167. Farrell, S., et al., Risk factors for Helicobacter pylori infection in children: an 
examination of the role played by intrafamilial bed sharing. Pediatr Infect Dis J, 
2005. 24(2): p. 149-52. 
168. Fox, J.G. and T.C. Wang, Reply to "The 'African enigma' - another explanation". 
Nat Med, 2000. 6(12): p. 1297-8. 
169. Fox, J.G., T.C. Wang, and C. Nagler-Anderson, The African enigma: the 
parasite's perspective. Gut, 2001. 49(1): p. 156-7. 
170. Akimoto, M., et al., [Correlation between serum anti CagA antibody and gastric 
disease]. Nippon Shokakibyo Gakkai Zasshi, 1996. 93(1): p. 69. 
171. Alarcon, T., et al., Prevalence of CagA and VacA antibodies in children with 
Helicobacter pylori-associated peptic ulcer compared to prevalence in pediatric 
patients with active or nonactive chronic gastritis. Clin Diagn Lab Immunol, 
2000. 7(5): p. 842-4. 
172. Al-Marhoon, M.S., S. Nunn, and R.W. Soames, The association between cagA+ 
H. pylori infection and distal gastric cancer: a proposed model. Dig Dis Sci, 
2004. 49(7-8): p. 1116-22. 
173. Al-Marhoon, M.S., S. Nunn, and R.W. Soames, Effects of cagA+ and cagA- 
strains of Helicobacter pylori on the human gastric mucus layer thickness. J 
Gastroenterol Hepatol, 2005. 20(8): p. 1246-52. 
174. Atherton, J.C., CagA, the cag pathogenicity island and Helicobacter pylori 
virulence. Gut, 1999. 44(3): p. 307-8. 
175. Atherton, J.C., CagA: a role at last. Gut, 2000. 47(3): p. 330-1. 
176. Azuma, T., et al., Correlation between variation of the 3' region of the cagA gene 
in Helicobacter pylori and disease outcome in Japan. J Infect Dis, 2002. 186(11): 
p. 1621-30. 
177. Evans, D.J., Jr. and D.G. Evans, Helicobacter pylori CagA: analysis of sequence 
diversity in relation to phosphorylation motifs and implications for the role of 
CagA as a virulence factor. Helicobacter, 2001. 6(3): p. 187-98. 
178. Handa, O., Y. Naito, and T. Yoshikawa, CagA protein of Helicobacter pylori: a 
hijacker of gastric epithelial cell signaling. Biochem Pharmacol, 2007. 73(11): p. 
1697-702. 
179. Salih, B.A., The role of the putative virulence markers (cagA and vacA ) of 
Helicobacter pylori in peptic ulcer disease. Saudi Med J, 2004. 25(7): p. 830-6. 
180. Suzuki, N., et al., Catalase, a specific antigen in the feces of human subjects 
infected with Helicobacter pylori. Clin Diagn Lab Immunol, 2002. 9(4): p. 784-8. 
181. Suzuki, N., et al., Production and application of new monoclonal antibodies 
specific for a fecal Helicobacter pylori antigen. Clin Diagn Lab Immunol, 2002. 
9(1): p. 75-8. 
182. Hirai, I., et al., A method for assessment of Helicobacter pylori genotype using 
stool specimens. FEMS Immunol Med Microbiol, 2009. 56(1): p. 63-6. 
183. Yamazaki, S., et al., Identification of Helicobacter pylori and the cagA genotype 
in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. 
FEMS Immunol Med Microbiol, 2005. 44(3): p. 261-8. 
85 
 
184. Sasaki, T., et al., Analysis of Helicobacter pylori Genotype in Stool Specimens of 
Asymptomatic People. Lab Medicine, 2009. 40(7): p. 412-414. 
185. Li, Y.H., et al., Clinical value of Helicobacter pylori stool antigen test, 
ImmunoCard STAT HpSA, for detecting H pylori infection. World J Gastroenterol, 
2004. 10(6): p. 913-4. 
186. Higashi, H., et al., Biological activity of the Helicobacter pylori virulence factor 
CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl 
Acad Sci U S A, 2002. 99(22): p. 14428-33. 
187. Chattopadhyay, S., et al., Virulence genes in Helicobacter pylori strains from 
West Bengal residents with overt H. pylori-associated disease and healthy 
volunteers. J Clin Microbiol, 2002. 40(7): p. 2622-5. 
188. Molnar, B., et al., Significantly elevated Helicobacter pylori density and different 
genotype distribution in erosions as compared with normal gastric biopsy 
specimen detected by quantitative real-time PCR. Eur J Gastroenterol Hepatol, 
2008. 20(4): p. 305-13. 
189. Debets-Ossenkopp, Y.J., et al., Characteristics of clinical Helicobacter pylori 
strains from Ecuador. J Antimicrob Chemother, 2003. 51(1): p. 141-5. 
190. Garcia, H., et al., [Prevalence of Helicobacter pylori in patients with gastric 
cancer in Panama]. Rev Med Panama, 1992. 17(3): p. 203-7. 
191. Perez Ferrari, R., et al., [Helicobacter pylori at Hospital Santo Tomas]. Rev Med 
Panama, 1993. 18(3): p. 229-32. 
192. Sierra Lopez, R., F. Bertoli, and E.F. Penafiel, [Helicobacter pylori infection and 
the risk of gastric carcinoma. Report of a case]. Rev Med Panama, 1994. 19(1): 
p. 48-54. 
193. Axon, A.T., Review article: is Helicobacter pylori transmitted by the gastro-oral 
route? Aliment Pharmacol Ther, 1995. 9(6): p. 585-8. 
194. Baker, K.H., et al., Effect of oxidizing disinfectants (chlorine, monochloramine, 
and ozone) on Helicobacter pylori. Appl Environ Microbiol, 2002. 68(2): p. 981-
4. 
195. Johnson, C.H., E.W. Rice, and D.J. Reasoner, Inactivation of Helicobacter pylori 
by chlorination. Appl Environ Microbiol, 1997. 63(12): p. 4969-70. 
196. Moreno, Y., et al., Survival and viability of Helicobacter pylori after inoculation 
into chlorinated drinking water. Water Res, 2007. 41(15): p. 3490-6. 
197. Giao, M.S., et al., Effect of chlorine on incorporation of Helicobacter pylori into 
drinking water biofilms. Appl Environ Microbiol, 2010. 76(5): p. 1669-73. 
198. Ferlay J, S.H., Bray F, Forman D, Mathers C and Parkin DM. (2008) 
GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC 
CancerBase No. 10 [Internet]. 
199. Asrat, D., et al., Prevalence of Helicobacter pylori infection among adult 
dyspeptic patients in Ethiopia. Ann Trop Med Parasitol, 2004. 98(2): p. 181-9. 
200. Lindkvist, P., et al., Age at acquisition of Helicobacter pylori infection: 
comparison of a high and a low prevalence country. Scand J Infect Dis, 1996. 
28(2): p. 181-4. 
201. Lindkvist, P., et al., Risk factors for infection with Helicobacter pylori--a study of 
children in rural Ethiopia. Scand J Infect Dis, 1998. 30(4): p. 371-6. 
202. Melo, E.T., et al., Seroprevalence of Helicobacter pylori antibodies in medical 
86 
 
students and residents in Recife, Brazil. J Clin Gastroenterol, 2003. 36(2): p. 134-
8. 
203. Rodrigues, M.N., et al., Helicobacter pylori infection in adults from a poor urban 
community in northeastern Brazil: demographic, lifestyle and environmental 
factors. Braz J Infect Dis, 2005. 9(5): p. 405-10. 
204. Santos, I.S., et al., Prevalence of Helicobacter pylori infection and associated 
factors among adults in Southern Brazil: a population-based cross-sectional 
study. BMC Public Health, 2005. 5: p. 118. 
205. Abdullah, A.M., et al., Helicobacter pylori infection in children in Saudi Arabia. 
Trop Gastroenterol, 1997. 18(2): p. 63-5. 
206. Mohamed, A.E., et al., Helicobacter pylori: incidence and comparison of three 
diagnostic methods in 196 Saudi patients with dyspepsia. Hepatogastroenterology, 
1994. 41(1): p. 48-50. 
207. Novis, B.H., G. Gabay, and T. Naftali, Helicobacter pylori: the Middle East 
scenario. Yale J Biol Med, 1998. 71(2): p. 135-41. 
208. Baena, J.M., et al., Relation between alcohol consumption and the success of 
Helicobacter pylori eradication therapy using omeprazole, clarithromycin and 
amoxicillin for 1 week. Eur J Gastroenterol Hepatol, 2002. 14(3): p. 291-6. 
209. Battaglia, G., et al., Helicobacter pylori infection, cigarette smoking and alcohol 
consumption. A histological and clinical study on 286 subjects. Ital J 
Gastroenterol, 1993. 25(8): p. 419-24. 
210. Brenner, H., et al., Alcohol consumption and Helicobacter pylori infection: results 
from the German National Health and Nutrition Survey. Epidemiology, 1999. 
10(3): p. 214-8. 
211. Banatvala, N. and R. Feldman, The epidemiology of Helicobacter pylori: missing 
pieces in a jigsaw. Commun Dis Rep CDR Rev, 1993. 3(4): p. R56-9. 
212. Cave, D.R., Transmission and epidemiology of Helicobacter pylori. Am J Med, 
1996. 100(5A): p. 12S-17S; discussion 17S-18S. 
213. Crespo, A. and B. Suh, Helicobacter pylori infection: epidemiology, 
pathophysiology, and therapy. Arch Pharm Res, 2001. 24(6): p. 485-98. 
214. Everhart, J.E., Recent developments in the epidemiology of Helicobacter pylori. 
Gastroenterol Clin North Am, 2000. 29(3): p. 559-78. 
215. Asaka, M., [Epidemiology of Helicobacter pylori infection in Japan]. Nippon 
Rinsho, 2003. 61(1): p. 19-24. 
216. Caballero Plasencia, A.M., et al., Epidemiology of dyspepsia in a random 
mediterranean population. Prevalence of Helicobacter pylori infection. Rev Esp 
Enferm Dig, 2000. 92(12): p. 781-92. 
217. Edwards, C.N., et al., Epidemiology of Helicobacter pylori infection in Barbados. 
West Indian Med J, 1997. 46(1): p. 3-7. 
218. Tovey, F., Peptic ulcer in India and Bangladesh. . Gut 1979. 20: p. 329-347. 
219. Keechilat Pavithran, D.C.D., and Kamal K. Pandey, Gastric cancer in India. 
Gastric Cancer, 2002. 5: p. 240–243. 
220. Gill, H.H. and H.G. Desai, Helicobacter pylori and gastroduodenal disorders in 
India--lessons from epidemiology. J Clin Gastroenterol, 1993. 16(1): p. 6-9. 
221. Jain, A., et al., Risk factors for duodenal ulcer in north India. Trop Gastroenterol, 
1999. 20(1): p. 36-9. 
87 
 
222. Jain, A.K. and V.M. Dayal, Helicobacter pylori recolonization and ulcer relapse 
after its eradication in India. Indian J Gastroenterol, 1997. 16 Suppl 1: p. S22-4. 
223. Katelaris, P.H., et al., Dyspepsia, Helicobacter pylori, and peptic ulcer in a 
randomly selected population in India. Gut, 1992. 33(11): p. 1462-6. 
224. Tovey, F.I., et al., Duodenal gastric metaplasia and Helicobacter pylori infection 
in high and low duodenal ulcer-prevalent areas in India. J Gastroenterol Hepatol, 
2004. 19(5): p. 497-505. 
225. Abraham, P., Helicobacter pylori: a review of practices and research in India. 
Indian J Gastroenterol, 1997. 16 Suppl 1: p. S1-2. 
226. Ahuja, V., The case for Helicobacter pylori eradication in India: sensationalism, 
skepticism and scientific salesmanship. Indian J Gastroenterol, 2006. 25(1): p. 20-
4. 
227. Mohandas, K.M., Problems with epidemiologic studies on Helicobacter pylori in 
India. Indian J Gastroenterol, 1997. 16 Suppl 1: p. S6-8. 
228. Jedrychowski, W., et al., Effect of Helicobacter pylori infection, smoking and 
dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-
epidemiological study in Poland. Pol J Pathol, 1999. 50(4): p. 289-95. 
229. Jenkins, D.J., Helicobacter pylori and its interaction with risk factors for chronic 
disease. Bmj, 1997. 315(7121): p. 1481-2. 
230. Singh, V., et al., Helicobacter pylori: evidence for spouse-to-spouse transmission. 
J Gastroenterol Hepatol, 1999. 14(6): p. 519-22. 
231. Misra, V., et al., Point prevalence of peptic ulcer and gastric histology in healthy 
Indians with Helicobacter pylori infection. Am J Gastroenterol, 1997. 92(9): p. 
1487-91. 
232. Bago, J., et al., Relationship of gastric metaplasia and age, sex, smoking and 
Helicobacter pylori infection in patients with duodenal ulcer and duodenitis. Coll 
Antropol, 2000. 24(1): p. 157-65. 
233. Bateson, M.C., Helicobacter pylori infection with age. Lancet, 1992. 339(8801): 
p. 1121. 
234. Camargo, M.C., et al., Age at acquisition of Helicobacter pylori infection: 
comparison of two areas with contrasting risk of gastric cancer. Helicobacter, 
2004. 9(3): p. 262-70. 
235. Choi, J.W., Does Helicobacter pylori infection relate to iron deficiency anaemia 
in prepubescent children under 12 years of age? Acta Paediatr, 2003. 92(8): p. 
970-2. 
236. Malaty, H.M., et al., Age at acquisition of Helicobacter pylori infection: a follow-
up study from infancy to adulthood. Lancet, 2002. 359(9310): p. 931-5. 
237. Sinha, S.K., et al., Age at acquisition of Helicobacter pylori in a pediatric 
Canadian First Nations population. Helicobacter, 2002. 7(2): p. 76-85. 
238. Tiwari, S.K., et al., Prognostic significance of genotyping Helicobacter pylori 
infection in patients in younger age groups with gastric cancer. Postgrad Med J, 
2008. 84(990): p. 193-7. 
239. Celinski, K., et al., The effects of environmental factors on the prevalence of 
Helicobacter pylori infection in inhabitants of Lublin Province. Ann Agric 
Environ Med, 2006. 13(2): p. 185-91. 
240. Chang, W.K., et al., Association between Helicobacter pylori infection and the 
88 
 
risk of gastric cancer in the Korean population: prospective case-controlled 
study. J Gastroenterol, 2001. 36(12): p. 816-22. 
241. Parente, J.M., et al., Helicobacter pylori infection in children of low and high 
socioeconomic status in northeastern Brazil. Am J Trop Med Hyg, 2006. 75(3): p. 
509-12. 
242. Nurgalieva Z, M.H., Graham DY, Almuchambetova R, Machmudova A, 
Kapsultanova D, Osato MS, Helicobacter pylori infection in Kazakhstan: effect of 
water source and household hygiene. Am J Trop Hyg, 2003. 67: p. 201–6. 
243. Sung, J., ed. Factors associated with disappearance of Helicobacter pylori in the 
Far East. . Helicobacter pylori: Basic Mechanisms to Clinical Cure., ed. T.G. 
Hunt RH, eds. Vol. 53. 2000, Dordrecht: Kluwer. 
244. Sitas, F., et al., Helicobacter pylori infection rates in relation to age and social 
class in a population of Welsh men. Gut, 1991. 32(1): p. 25-8. 
245. An international association between Helicobacter pylori infection and gastric 
cancer. The EUROGAST Study Group. Lancet, 1993. 341(8857): p. 1359-62. 
246. Buckley, M.J., et al., A community-based study of the epidemiology of 
Helicobacter pylori infection and associated asymptomatic gastroduodenal 
pathology. Eur J Gastroenterol Hepatol, 1998. 10(5): p. 375-9. 
247. Palli, D., et al., Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a 
molecular epidemiology study in Italy. Cancer Epidemiol Biomarkers Prev, 1997. 
6(12): p. 1065-9. 
248. Shah, S., et al., Evaluation of the factors influencing stomach-specific delivery of 
antibacterial agents for Helicobacter pylori infection. J Pharm Pharmacol, 1999. 
51(6): p. 667-72. 
249. Matsubara, S., et al., Suppression of Helicobacter pylori-induced gastritis by 
green tea extract in Mongolian gerbils. Biochem Biophys Res Commun, 2003. 
310(3): p. 715-9. 
250. al Somal, N., et al., Susceptibility of Helicobacter pylori to the antibacterial 
activity of manuka honey. J R Soc Med, 1994. 87(1): p. 9-12. 
251. Tabak, M., et al., In vitro inhibition of Helicobacter pylori by extracts of thyme. J 
Appl Bacteriol, 1996. 80(6): p. 667-72. 
252. Nariman, F., et al., Anti-Helicobacter pylori activities of six Iranian plants. 
Helicobacter, 2004. 9(2): p. 146-51. 
253. Bellinghausen, I., et al., Signals involved in the early TH1/TH2 polarization of an 
immune response depending on the type of antigen. J Allergy Clin Immunol, 
1999. 103(2 Pt 1): p. 298-306. 
254. D'Elios, M.M., A. Amedei, and G. Del Prete, Helicobacter pylori antigen-specific 
T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer 
and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma. Microbes 
Infect, 2003. 5(8): p. 723-30. 
255. Ernst, P., Review article: the role of inflammation in the pathogenesis of gastric 
cancer. Aliment Pharmacol Ther, 1999. 13 Suppl 1: p. 13-8. 
256. Bamford, K.B., et al., Lymphocytes in the human gastric mucosa during 
Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology, 1998. 
114(3): p. 482-92. 
257. D'Elios, M.M., et al., Gastric autoimmunity: the role of Helicobacter pylori and 
89 
 
molecular mimicry. Trends Mol Med, 2004. 10(7): p. 316-23. 
258. D'Elios, M.M., et al., Helicobacter pylori and gastric autoimmunity. Microbes 
Infect, 2004. 6(15): p. 1395-401. 
259. D'Elios, M.M., et al., T helper 1 effector cells specific for Helicobacter pylori in 
the gastric antrum of patients with peptic ulcer disease. J Immunol, 1997. 158(2): 
p. 962-7. 
260. Marshall, B., Helicobacter pylori: 20 years on. Clin Med, 2002. 2(2): p. 147-52. 
261. Bazzoli, F. and P. Pozzato, Therapy of H. pylori infection. J Physiol Pharmacol, 
1997. 48 Suppl 4: p. 39-46. 
262. Lind, T., et al., Eradication of Helicobacter pylori using one-week triple therapies 
combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter, 
1996. 1(3): p. 138-44. 
263. Malhotra, S. and P. Pandhi, Eradication of Helicobacter pylori: current 
perspectives. Expert Opin Pharmacother, 2002. 3(8): p. 1031-8. 
264. Unge, P., Antibiotic treatment of Helicobacter pylori infection. Curr Top 
Microbiol Immunol, 1999. 241: p. 261-300. 
265. Watanabe, T., et al., Helicobacter pylori infection induces gastric cancer in 
mongolian gerbils. Gastroenterology, 1998. 115(3): p. 642-8. 
266. Uemura, N., S. Okamoto, and S. Yamamoto, H. pylori infection and the 
development of gastric cancer. Keio J Med, 2002. 51 Suppl 2: p. 63-8. 
267. Wong, B.C., et al., Helicobacter pylori eradication to prevent gastric cancer in a 
high-risk region of China: a randomized controlled trial. Jama, 2004. 291(2): p. 
187-94. 
268. Wotherspoon, A.C., et al., Regression of primary low-grade B-cell gastric 
lymphoma of mucosa-associated lymphoid tissue type after eradication of 
Helicobacter pylori. Lancet, 1993. 342(8871): p. 575-7. 
269. Stolte, M. and M. Vieth, Gastritis and gastric cancer: which morphological type 
of Helicobacter gastritis is a precancerous risk? Chin J Dig Dis, 2005. 6(3): p. 
110-1. 
270. Correa, P., Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol, 
1995. 19 Suppl 1: p. S37-43. 
271. Shikata, K., et al., A prospective study of dietary salt intake and gastric cancer 
incidence in a defined Japanese population: the Hisayama study. Int J Cancer, 
2006. 119(1): p. 196-201. 
272. Kountouras, J., C. Zavos, and D. Chatzopoulos, Salt intake and Helicobacter 
pylori infection. J Hypertens, 2004. 22(12): p. 2397. 
273. Nozaki, K., et al., Synergistic promoting effects of Helicobacter pylori infection 
and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer 
Res, 2002. 93(10): p. 1083-9. 
274. Tsugane, S., Salt, salted food intake, and risk of gastric cancer: epidemiologic 
evidence. Cancer Sci, 2005. 96(1): p. 1-6. 
275. Tsugane, S., et al., Salt and salted food intake and subsequent risk of gastric 
cancer among middle-aged Japanese men and women. Br J Cancer, 2004. 90(1): 
p. 128-34. 
276. Willis, P., et al., Cell proliferation in the post-surgical stomach, dietary salt, and 
the effect of H pylori eradication. J Clin Pathol, 1999. 52(9): p. 665-9. 
90 
 
277. Buiatti E, P.D., DeCarli A. , A case-control study of gastric cancer and diet in 
Italy. Int J Cancer, 1989. 44: p. 611. 
278. Gonzalez, C.A., Vegetable, fruit and cereal consumption and gastric cancer risk. 
IARC Sci Publ, 2002. 156: p. 79-83. 
279. Gonzalez, C.A., et al., Meat intake and risk of stomach and esophageal 
adenocarcinoma within the European Prospective Investigation Into Cancer and 
Nutrition (EPIC). J Natl Cancer Inst, 2006. 98(5): p. 345-54. 
280. Nomura, A., Searching for the causes of gastric cancer. Hawaii Med J, 2002. 
61(2): p. 33-4. 
281. Nomura, A. and G.N. Stemmermann, Helicobacter pylori and gastric cancer. J 
Gastroenterol Hepatol, 1993. 8(3): p. 294-303. 
282. Kneller, R.W., et al., Risk factors for stomach cancer in sixty-five Chinese 
counties. Cancer Epidemiol Biomarkers Prev, 1992. 1(2): p. 113-8. 
283. Tarpila, S., et al., Morphology and dynamics of the gastric mucosa in duodenal 
ulcer patients and their first-degree relatives. Hepatogastroenterology, 1983. 
30(5): p. 198-201. 
284. Tarpila, S., et al., Endoscopic and clinical findings in first-degree relative of 
duodenal ulcer patients and control subjects. Scand J Gastroenterol, 1982. 17(4): 
p. 503-6. 
285. Valle, J., et al., Helicobacter pylori and duodenal ulcer. A study of duodenal ulcer 
patients and their first-degree relatives. Scand J Gastroenterol Suppl, 1991. 186: 
p. 45-51. 
286. Weil, J., et al., Helicobacter pylori and metronidazole resistance. Lancet, 1990. 
336(8728): p. 1445. 
287. Cattoir, V., et al., Update on fluoroquinolone resistance in Helicobacter pylori: 
new mutations leading to resistance and first description of a gyrA polymorphism 
associated with hypersusceptibility. Int J Antimicrob Agents, 2007. 29(4): p. 389-
96. 
288. Fischbach, L. and E.L. Evans, Meta-analysis: the effect of antibiotic resistance 
status on the efficacy of triple and quadruple first-line therapies for Helicobacter 
pylori. Aliment Pharmacol Ther, 2007. 26(3): p. 343-57. 
289. Hu, C.T., et al., Resistance rate to antibiotics of Helicobacter pylori isolates in 
eastern Taiwan. J Gastroenterol Hepatol, 2007. 22(5): p. 720-3. 
290. Khurana, R., et al., Meta-analysis: Helicobacter pylori eradication treatment 
efficacy in children. Aliment Pharmacol Ther, 2007. 25(5): p. 523-36. 
291. Latifi-Navid, S., et al., Antimicrobial effectiveness of ketoconazole against 
metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic 
patients. J Antimicrob Chemother, 2007. 59(1): p. 160-1. 
292. Morales-Espinosa, R., et al., Susceptibility profile to common antimicrobials used 
for eradication of Helicobacter pylori Infection in Mexico by agar dilution 
method. J Chemother, 2007. 19(1): p. 108-9. 
293. Raymond, J., et al., Clarithromycin resistance in Helicobacter pylori strains 
isolated from French children: prevalence of the different mutations and 
coexistence of clones harboring two different mutations in the same biopsy. 
Helicobacter, 2007. 12(2): p. 157-63. 
294. Lee, C.C., et al., Levofloxacin-resistant Helicobacter pylori in Hong Kong. 
91 
 
Chemotherapy, 2008. 54(1): p. 50-3. 
295. Miehlke, S., et al., One-week once-daily triple therapy with esomeprazole, 
moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori 
resistant to both metronidazole and clarithromycin. Helicobacter, 2008. 13(1): p. 
69-74. 
296. Broussard, C.S., et al., Exposure to antibiotics in a United States-Mexico border 
birth cohort. Pediatrics, 2010. 125(6): p. e1468-74. 
297. Bhatia, S.J. and S.G. Kulkarni, Cost-effectiveness of Helicobacter pylori 
eradication in India: to live and let live ... expensively? Indian J Gastroenterol, 
1997. 16 Suppl 1: p. S25-8. 
298. Mishra, K.K., et al., Antibiotic susceptibility of Helicobacter pylori clinical 
isolates: comparative evaluation of disk-diffusion and E-test methods. Curr 
Microbiol, 2006. 53(4): p. 329-34. 
299. Ramteke, S. and N.K. Jain, Clarithromycin- and omeprazole-containing gliadin 
nanoparticles for the treatment of Helicobacter pylori. J Drug Target, 2008. 
16(1): p. 65-72. 
300. Azuma, T., et al., Diversity of vacA and cagA genes of Helicobacter pylori in 
Japanese children. Aliment Pharmacol Ther, 2004. 20 Suppl 1: p. 7-12. 
301. Fu, H.Y., et al., East Asian-type Helicobacter pylori cytotoxin-associated gene A 
protein has a more significant effect on growth of rat gastric mucosal cells than 
the Western type. J Gastroenterol Hepatol, 2007. 22(3): p. 355-62. 
302. Kanada, R., et al., Genotyping of the cagA gene of Helicobacter pylori on 
immunohistochemistry with East Asian CagA-specific antibody. Pathol Int, 2008. 
58(4): p. 218-25. 
303. Kim, S.Y., et al., Helicobacter pylori CagA transfection of gastric epithelial cells 
induces interleukin-8. Cell Microbiol, 2006. 8(1): p. 97-106. 
304. Satomi, S., et al., Relationship between the diversity of the cagA gene of 
Helicobacter pylori and gastric cancer in Okinawa, Japan. J Gastroenterol, 2006. 
41(7): p. 668-73. 
305. Uchida, T., et al., Immunohistochemical diagnosis of the cagA-gene genotype of 
Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci, 
2007. 98(4): p. 521-8. 
306. Zhou, W., et al., The diversity of vacA and cagA genes of Helicobacter pylori in 
East Asia. FEMS Immunol Med Microbiol, 2004. 40(1): p. 81-7. 
 
 
